<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Immunol</journal-id><journal-title>BMC Immunology</journal-title><issn pub-type="epub">1471-2172</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1471-2172-8-17</article-id><article-id pub-id-type="pmid">17705868</article-id><article-id pub-id-type="doi">10.1186/1471-2172-8-17</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Transcription factor network downstream of protease activated receptors (PARs) modulating mouse bladder inflammation</article-title></title-group><contrib-group><contrib id="A1" corresp="yes" contrib-type="author"><name><surname>Saban</surname><given-names>Ricardo</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>ricardo-saban@ouhsc.edu</email></contrib><contrib id="A2" contrib-type="author"><name><surname>Simpson</surname><given-names>Cindy</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>cindy-simpson@ouhsc.edu</email></contrib><contrib id="A3" contrib-type="author"><name><surname>Davis</surname><given-names>Carole A</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>carole-davis@ouhsc.edu</email></contrib><contrib id="A4" contrib-type="author"><name><surname>Dozmorov</surname><given-names>Igor</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>igor-dozmorov@omrf.ouhsc.edu</email></contrib><contrib id="A5" contrib-type="author"><name><surname>Maier</surname><given-names>Julie</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>maierj@omrf.ouhsc.edu</email></contrib><contrib id="A6" contrib-type="author"><name><surname>Fowler</surname><given-names>Ben</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>fowlerb@omrf.ouhsc.edu</email></contrib><contrib id="A7" contrib-type="author"><name><surname>Ihnat</surname><given-names>Michael A</given-names></name><xref ref-type="aff" rid="I4">4</xref><email>michael-ihnat@ouhsc.edu</email></contrib><contrib id="A8" contrib-type="author"><name><surname>Hurst</surname><given-names>Robert E</given-names></name><xref ref-type="aff" rid="I5">5</xref><email>robert-hurst@ouhsc.edu</email></contrib><contrib id="A9" contrib-type="author"><name><surname>Wershil</surname><given-names>Barry K</given-names></name><xref ref-type="aff" rid="I6">6</xref><email>Bwershil@montefiore.org</email></contrib><contrib id="A10" contrib-type="author"><name><surname>Saban</surname><given-names>Marcia R</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>marcia-saban@ouhsc.edu</email></contrib></contrib-group><aff id="I1"><label>1</label>Department of Physiology, The University Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA</aff><aff id="I2"><label>2</label>Oklahoma Medical Research Foundation (OMRF), Imaging Core Facility, Oklahoma City, Oklahoma 73104, USA</aff><aff id="I3"><label>3</label>Oklahoma Medical Research Foundation (OMRF), Arthritis and Immunology Research Program, Microarray/Euk. Genomics Core Facility, Oklahoma City, Oklahoma 73104. USA</aff><aff id="I4"><label>4</label>Department of Cell Biology, The University Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA</aff><aff id="I5"><label>5</label>Department of Urology, The University Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA</aff><aff id="I6"><label>6</label>Albert Einstein College of Medicine Division of Pediatric GI and Nutrition The Children's Hospital at Montefiore Bronx, NY 10467, USA</aff><pub-date pub-type="collection"><year>2007</year></pub-date><pub-date pub-type="epub"><day>17</day><month>8</month><year>2007</year></pub-date><volume>8</volume><fpage>17</fpage><lpage>17</lpage><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2172/8/17"/><history><date date-type="received"><day>22</day><month>6</month><year>2007</year></date><date date-type="accepted"><day>17</day><month>8</month><year>2007</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2007 Saban et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2007</copyright-year><copyright-holder>Saban et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p><!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author> Saban Ricardo ricardo-saban@ouhsc.edu </dc:author><dc:title> Transcription factor network downstream of protease activated receptors (PARs) modulating mouse bladder inflammation </dc:title><dc:date>2007</dc:date><dcterms:bibliographicCitation>BMC Immunology 8(1): 17-. (2007)</dcterms:bibliographicCitation><dc:identifier type="sici">1471-2172(2007)8:1&#x0003c;17&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1471-2172</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>--></license></permissions><abstract><sec><title>Background</title><p>All four PARs are present in the urinary bladder, and their expression is altered during inflammation. In order to search for therapeutic targets other than the receptors themselves, we set forth to determine TFs downstream of PAR activation in the C57BL/6 urinary bladders.</p></sec><sec sec-type="methods"><title>Methods</title><p>For this purpose, we used a protein/DNA combo array containing 345 different TF consensus sequences. Next, the TF selected was validated by EMSA and IHC. As mast cells seem to play a fundamental role in bladder inflammation, we determined whether c-kit receptor deficient (Kit<sup>w</sup>/Kit<sup>w-v</sup>) mice have an abrogated response to PAR stimulation. Finally, TFEB antibody was used for CHIP/Q-PCR assay and revealed up-regulation of genes known to be downstream of TFEB.</p></sec><sec><title>Results</title><p>TFEB, a member of the MiTF family of basic helix-loop-helix leucine zipper, was the only TF commonly up-regulated by all PAR-APs. IHC results confirm a correlation between inflammation and TFEB expression in C57BL/6 mice. In contrast, Kit<sup>w</sup>/Kit<sup>w-v </sup>mice did not exhibit inflammation in response to PAR activation. EMSA results confirmed the increased TFEB binding activity in C57BL/6 but not in Kit<sup>w</sup>/Kit<sup>w-v </sup>mice.</p></sec><sec><title>Conclusion</title><p>This is the first report describing the increased expression of TFEB in bladder inflammation in response to PAR activation. As TFEB belongs to a family of TFs essential for mast cell survival, our findings suggest that this molecule may influence the participation of mast cells in PAR-mediated inflammation and that targeting TFEB/MiTF activity may be a novel approach for the treatment of bladder inflammatory disorders.</p></sec></abstract></article-meta></front><body><sec><title>Background</title><p>Attesting to the importance of inflammation in disease, a trans-NIH Inflammation Working Group was formed recently to collect input on proposed research areas within the overarching theme of "Inflammation as a Common Mechanism of Disease" [<xref ref-type="bibr" rid="B1">1</xref>]. In general, inflammation plays a role in most bladder pathologies, including bladder cancer [<xref ref-type="bibr" rid="B2">2</xref>-<xref ref-type="bibr" rid="B5">5</xref>], and represents a defensive reaction to injury caused by physical damage, chemical substances, micro-organisms, or other agents [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>]. In particular, several lines of evidence suggest that neurogenic bladder inflammation involves the participation of mast cells and sensory nerves. We previously demonstrated a key role for mast cells and their products in bladder inflammation [<xref ref-type="bibr" rid="B6">6</xref>-<xref ref-type="bibr" rid="B8">8</xref>]. As a consequence of inflammation, products of mast cell degranulation, such as tryptase, can be found in the urine of both bladder cancer and cystitis patients [<xref ref-type="bibr" rid="B9">9</xref>]. In addition to tryptase, other serine proteases, such as thrombin and trypsin, are produced during tissue damage and make important contributions to tissue responses to injury, repair, cell survival, inflammation [<xref ref-type="bibr" rid="B10">10</xref>-<xref ref-type="bibr" rid="B13">13</xref>], and pain [<xref ref-type="bibr" rid="B14">14</xref>-<xref ref-type="bibr" rid="B18">18</xref>]. Tissue responses to these enzymes are modulated by protease-activated receptors (PARs), a unique class of G protein-coupled receptors that use a fascinating mechanism to convert an extracellular proteolytic cleavage event into a trans-membrane signal. These receptors carry their own ligands, which remain cryptic until unmasked by receptor cleavage (for a review, please see references [<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B17">17</xref>,<xref ref-type="bibr" rid="B19">19</xref>,<xref ref-type="bibr" rid="B20">20</xref>]).</p><p>Four PARs have been cloned so far, and all are co-expressed in the mouse bladder urothelium [<xref ref-type="bibr" rid="B21">21</xref>] and human urothelial cells [<xref ref-type="bibr" rid="B22">22</xref>]. In addition to the urothelium, PAR1 and PAR2 are also expressed in mouse detrusor muscle, and PAR4 is expressed in mouse peripheral nerves and plexus cell bodies [<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B22">22</xref>]. The expression of PARs is altered during inflammation [<xref ref-type="bibr" rid="B21">21</xref>]. Additional evidence for the participation of PARs in the bladder inflammatory response was the finding that known pro-inflammatory stimuli, such as LPS, substance P, and antigen challenge, induce an increase in PAR4 RNA within hours of stimulation [<xref ref-type="bibr" rid="B23">23</xref>]. Moreover, up-regulation of PAR protein levels have been shown to be part of rat bladder responses to cyclophosphamide [<xref ref-type="bibr" rid="B24">24</xref>].</p><p>PAR1- and to a lesser extent PAR2-deficient mice exhibit a reduced response to bladder inflammation induced by <italic>E. coli</italic> lipopolysaccharide (LPS), substance P, and antigen [<xref ref-type="bibr" rid="B22">22</xref>]. The latter indicate that these receptors are upstream of a cascade of events leading to bladder inflammation [<xref ref-type="bibr" rid="B22">22</xref>,<xref ref-type="bibr" rid="B25">25</xref>]. In addition, regardless of the pro-inflammatory stimuli, the urinary bladder inflammatory transcriptome includes a sub-set of genes that are dependent on PAR activation [<xref ref-type="bibr" rid="B26">26</xref>].</p><p>Despite the evidence of PAR involvement in inflammation, pain, healing, and cancer in animal models, there seems to be no published clinical study regarding the efficacy of PAR antagonists. In order to search for therapeutic targets other than receptors themselves, we set forth to determine the transcription factors downstream of PAR activation as the next step in elucidating the network of responses at the molecular level to PAR activation. For this purpose, we introduced a new approach for the study of the transcriptional regulation downstream PAR activation (Figure <xref ref-type="fig" rid="F1">1</xref>). This top-down approach started by selecting a candidate TF out of 345 different TF consensus sequences present in a protein/DNA combo array (Panomics). Next, PAR-induced alteration in this TF binding was validated by EMSA and IHC was used to confirm its expression in the urinary bladder. Finally, an antibody recognizing this TF was used for CHIP/Q-PCR assay and revealed up-regulation of downstream genes.</p><fig position="float" id="F1"><label>Figure 1</label><caption><p>Molecular Approach. A top-down approach was used to determine transcription factors involved in the response of the mouse bladder to pro-inflammatory PAR-APs. This approach started by selecting a candidate TF out of 345 different TF consensus sequences present in a protein/DNA combo array (Panomics). Next, PAR-induced alteration in this TF binding was validated by EMSA and IHC was used to confirm its expression in the urinary bladder. Finally, an antibody recognizing this TF was used for CHIP/Q-PCR assay and revealed up-regulation of downstream genes.</p></caption><graphic xlink:href="1471-2172-8-17-1"/></fig></sec><sec sec-type="methods"><title>Methods</title><sec><title>Animals</title><p>All animal experimentation described here was performed in conformity with the "Guiding Principles for Research Involving Animals and Human Beings" (The studies have been reviewed and approved by the institutional review committee protocols 05-088I and 05-081). Genetically mast cell-deficient WBB6F1-Kit<sup>w</sup>/Kit<sup>w-v </sup>and normal C57BL/6 mice were purchased from Jackson Laboratories (Bar Harbor, ME).</p></sec><sec><title>Induction of cystitis</title><p>Acute cystitis was induced as we described previously [<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B23">23</xref>,<xref ref-type="bibr" rid="B27">27</xref>-<xref ref-type="bibr" rid="B29">29</xref>]. Briefly, 8&#x02013;10 week old female mice were anesthetized with isoflurane using a precision vaporizer, then transurethrally catheterized (24 Ga.; 3/4 in; Angiocath, Becton Dickson, Sandy, Utah), and the urine was drained by applying slight digital pressure to the lower abdomen. The urinary bladders were instilled on two consecutive days with 200 &#x003bc;l of one of the following substances: PAR-activating peptides (PAR1-AP = SFFLRN [<xref ref-type="bibr" rid="B30">30</xref>]; PAR2-AP = SLIGRL [<xref ref-type="bibr" rid="B30">30</xref>]; PAR4-AP = AYPGKF [<xref ref-type="bibr" rid="B31">31</xref>], and control inactive peptide = LRGILS [<xref ref-type="bibr" rid="B30">30</xref>]). All peptides were used at 10 &#x003bc;M concentration [<xref ref-type="bibr" rid="B22">22</xref>]. Substances were infused at a slow rate to avoid trauma and vesicoureteral reflux [<xref ref-type="bibr" rid="B18">18</xref>]. To ensure consistent contact of substances with the bladder, infusion was repeated twice within a 30-min interval and a 1-ml Tb syringe was maintained on the catheter end retaining the intravesical solution for at least 1 hour. Afterwards, the catheter was removed and the mice were allowed to void normally. Twenty-four hours post the second instillation, animals were euthanized by cervical dislocation and bladders were rapidly removed and frozen for immunohistochemistry or placed in cold PBS with protease (Protease Inhibitor Cocktail, Sigma, St. Louis, MO) and phosphatase inhibitors (20 mM sodium fluoride, 1 mM &#x003b2;-glycerophosphate, and 1 mM sodium orthovanadate) for separation of the urothelium/submucosa away from the detrusor smooth muscle.</p></sec><sec><title>Separating the mucosa from the detrusor smooth muscle [<xref ref-type="bibr" rid="B32">32</xref>]</title><p>To decrease the complexity of using whole bladder homogenates, the bladder mucosa was separated from the detrusor smooth muscle, as described [<xref ref-type="bibr" rid="B32">32</xref>]. Briefly, immediately after removal from the animal, bladders were placed in PBS with protease inhibitors on ice and visualized under a dissecting microscope (Nikon SMZ 1500) and the detrusor smooth muscle was separated by blunt dissection away from the mucosa which contained the epithelium and sub-epithelial layers. Isolated layers were flash frozen and stored at -80&#x000b0;C until processing. Tissues were pulverized in a spring-loaded tissue pulverizer (Bio-Pulverizer, Biospec Products, Bartlesville, OK) and chilled with liquid nitrogen. Nuclear and cytosolic extracts were prepared using the Pierce NE-PER kit that enables stepwise separation and preparation of cytoplasmic and nuclear extracts from bladder tissue, as described [<xref ref-type="bibr" rid="B26">26</xref>]. Addition of the first two reagents (Pierce's proprietary information) to the pulverized tissue causes disruption of cell membranes and release of cytoplasmic contents. After recovering the intact nuclei from the cytoplasmic extract by centrifugation at 16,000 &#x000d7; g for 5 minutes, the nuclei are lysed with a third reagent (Pierce's proprietary information) to yield the nuclear extract. Extracts obtained with this product generally have less than 10% contamination between nuclear and cytoplasmic fractions &#x02013; sufficient purity for most experiments involving nuclear extracts. A western blot was prepared using the nuclear and cytosolic extracts and probed for the nuclear proteins histone H3 and lamin A/C. No nuclear contamination was shown in the cytosolic fractions (data not shown). Protein concentrations were determined with a Micro BCA kit (Pierce, Rockford, IL) per manufacturer's instructions.</p></sec><sec><title>Analysis of transcriptional regulatory network by protein/DNA combo arrays</title><p>Minimum Information About Microarray Experiments &#x02013; MIAME [<xref ref-type="bibr" rid="B33">33</xref>].</p><sec><title>Objective</title><p>To determine the transcriptional regulatory elements (TRE) downstream of the activation of PAR receptor. For this purpose, female C57BL6 mice (n = 3 per group) were instilled two times, 30 minutes part, with: control peptide, PAR1-AP, PAR2-AP, or PAR4-AP, every other day for 3 days. All peptides were used at 10 &#x003bc;M concentration. Mice were euthanized 24 hours after the last instillation and the urinary bladders were isolated, and the mucosa was separated from the detrusor muscle, as described above.</p></sec><sec><title>Array Design</title><p>Nuclear extracts from the bladder mucosa were obtained as detailed below for EMSA assays and analyzed by protein/DNA combo arrays containing 345 unique consensus-binding sequences per array [<xref ref-type="bibr" rid="B34">34</xref>].</p></sec><sec><title>Hybridization</title><p>To investigate the relative binding of TREs to their unique consensus sequences, we used the TransSignal protein/DNA combo array with spin column preparation (catalog no. MA1215) from Panomics (Fremont, CA) [<xref ref-type="bibr" rid="B34">34</xref>]. Array analysis was performed as per the manufacturer's instructions using nuclear extracts from mouse bladders before and after exposure to PAR-APs or control peptide. Nuclear extracts were prepared using the Panomics nuclear extraction kit (catalog no. AY2002) as per the manufacturer's instructions. Fifteen micrograms of nuclear extract were isolated before and after challenge, and they were incubated with 10 &#x003bc;l of TransSignal probe mix (Panomics) containing 345 biotin-labeled double-stranded DNA oligonucleotides. TFs bound to the double-stranded oligonucleotides were recovered by using the Panomics spin column. The biotin-labeled oligonucleotides specifically bound to the TREs were eluted and hybridized to the TransSignal array membrane containing oligonucleotides (representing 345 consensus binding sites for TREs) overnight at 42&#x000b0;C. The blots were then washed and incubated with a horseradish peroxidase (HRP)-conjugated streptavidin according to the manufacturer's instructions. The resulting spots were visualized on a FluorChem Imager (Alpha Innotech, San Leandro, CA). The images were quantified with AlphaEase FC software (Alpha Innotech) and the results were analyzed as described below.</p></sec><sec><title>Data normalization and analysis</title><p>We used the same methodology developed for analysis of cDNA microarrays [<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B23">23</xref>,<xref ref-type="bibr" rid="B27">27</xref>,<xref ref-type="bibr" rid="B35">35</xref>,<xref ref-type="bibr" rid="B36">36</xref>]. Briefly, the raw data obtained with all Panomic membranes was first queried to determine only TFs expressed above background, as described for cDNA microarrays, and each expressed data was then log10 transformed. In addition, pairs of groups (control vs challenged) were adjusted to all data and then to each other using a robust regression analysis. Normalization was conducted using an iterative nonlinear curve-fitting procedure, as described [<xref ref-type="bibr" rid="B37">37</xref>]. This procedure assumes that intensities corresponding to TFs not expressed by the tissue will be normally distributed, and computes the mean and standard deviation (SD). Next, we normalized each expression profile to its own background (defined by adjusting a mean = 0 and SD = 1 of the distribution of non-expressed TFs). For further analysis, data obtained after normalization of each profile to its own background were log-transformed with substitution of negative values by the minimal logarithmic value obtained within positive values. Next, a robust regression analysis was conducted on expressed TFs. This analysis was based on the fact that, in a linear regression analysis between two compared samples, the majority of TFs are equally expressed and, therefore, randomly distributed around the regression line with a small portion of differentially expressed "outliers." The contribution of outliers to the regression analysis was down-weighted in an iterative manner. All expression profiles of both control and experimental groups were then rescaled to a common standard: the averaged profile of the control group. Our procedure for outlier exclusion was based on the selection of equally expressed TFs with close to normal distributed residuals (measured as deviations from the regression line). Only transcriptional factors exhibiting a ratio greater than 3.0 between control and treated groups are being presented.</p></sec><sec><title>Electrophoresis motility assays (EMSAs)</title><p>A commercially available double-stranded TFEB probe corresponding to the adenovirus major late promoter core sequence (5'-G TAG GCC ACG TGA CCG GG-3', 3'-C ATC CGG TGC ACT GGC CC-5', Santa Cruz Biotechnology, Santa Cruz, CA) was constructed by end-labeling a double-stranded probe with &#x003b3;<sup>32</sup>P ATP (3000 Ci/mmole; GE Healthcare) and T4 polynucleotide kinase (New England Biolabs) and then purified using a G-50 column (GE Healthcare). A second probe corresponding to the &#x003bc;E3 immunoglobulin enhancer site (5'-GAT CTG GTC GTG TGG CAA GGC-3', 3'-CTA GAC CAG TAC ACC GTT CCG-5'; Santa Cruz Biotechnology) was also tested but it was found to have a much lower binding affinity as previously described by others [<xref ref-type="bibr" rid="B38">38</xref>] (data not shown).</p><p>Nuclear extracts (10 &#x003bc;g) from the bladder mucosa and detrusor muscle were placed in 10 mM Tris HCl pH 7.9, 100 mM KCl, 5 mM MgCl<sub>2</sub>, 1 mM EDTA, 5% glycerol, 0.02% NP-40, 1 &#x003bc;g poly dI-dC, 1 mM DTT with protease and phosphatase inhibitors were added to 10,000 cpm labeled TFEB consensus oligonucleotide and incubated at room temperature for 20 minutes. Cold reactions contained 100&#x000d7; unlabeled TFEB consensus oligonucleotide. For super-shift reactions, 10 &#x003bc;g of nuclear extract was pre-incubated for 30 minutes on ice with 1.5 &#x003bc;g TFEB antibody (Abcam, Cambridge, MA). Reactions were resolved on a 5% native acrylamide gel with 0.5 &#x000d7; TBE at 300 V for 2 hours. Gels were vacuum-dried and visualized on Kodak Biomax MS Film and quantified using ImageJ Software (NIH) [<xref ref-type="bibr" rid="B39">39</xref>].</p></sec><sec><title>TFEB Immunofluorescence</title><p>Frozen bladders were processed for routine immunohistochemistry according to published methods [<xref ref-type="bibr" rid="B27">27</xref>]. All reagent incubations and washes were performed at room temperature. Normal blocking serum (Jackson Immunolabs) was placed on all slides for 45 min and sections were incubated with primary antibody (Goat anti-TFEB N-term 2&#x02013;14, ab2636 Abcam) at concentrations of 1, 2, and 4 &#x003bc;g/ml. Controls include omission of the primary antibody. Slides were washed and incubated with secondary antibodies (Alexa Fluor 546 donkey anti-goat IgG, A11056, Invitrogen). Slides were washed, counterstained with DAPI and coverslipped with Shur/Mount (TBS) mounting media. All tissues were imaged at room temperature using Axiovision 4.6 and a Zeiss axiocam HRm high-resolution CCD camera. Selected sections were visualized and photographed using a Zeiss LSM510 Laser Scanning Confocal with META (Thornwood, NY). TFEB fluorescence was analyzed in triplicate by Image analysis of the urothelial cell layer. Images were analyzed with Image-Pro Analyzer<sup>&#x000ae; </sup>(Media Cybernetics Inc.; Silver Spring, MD) and the area expressing positive cells for TFEB at 200&#x000d7; magnification was calculated as percent of the total urothelial cell area. Results are presented as average and standard error of the mean.</p></sec><sec><title>Target validation by Q-PCR of Chromatin Immunoprecipitation (CHIP)-Based Assays</title><p>Target validation was sought for 7 genes known to have an E-box based on the evidence on the literature (E-cadherin, serpine 1, IGF1R, WT1, cyclin D1, and cathepsin K) or our own observation Eif4ebp2 [<xref ref-type="bibr" rid="B32">32</xref>]. Female C57BL/6J mice (n = 20 per group) were anesthetized (ketamine 200 mg/kg and xylazine 2.5 mg/kg, i.p.), and instilled on two consecutive days with 200 &#x003bc;l of one of the following substances: PAR2-AP [SLIGRL [<xref ref-type="bibr" rid="B30">30</xref>]] or control inactive peptide [LRGILS [<xref ref-type="bibr" rid="B30">30</xref>]]. Twenty-four hours after instillation, mice were euthanized with pentobarbital (200 mg/kg, i.p.) and the whole bladders removed rapidly and frozen.</p><p>Frozen bladders were shipped to Genpathway [<xref ref-type="bibr" rid="B40">40</xref>] for querying the chromatin for detection and quantification of TFEB binding upstream of specific genes using chromatin immunopreciptation (ChIP) combined with real time PCR (Q-PCR) (Genpathway's FactorPath Query assay) [<xref ref-type="bibr" rid="B41">41</xref>]. The whole bladders, contained both the mucosa and detrusor layers, were exposed briefly to formaldehyde for cross-linking of the proteins and DNA together, followed by sonication to fragment the DNA into pieces of approximately 300&#x02013;500 bp. The same TFEB antibody used for IHC (Abcam, Cambridge, MA) was then used to precipitate the TFEB-DNA complexes. The Ab-protein-DNA complexes were purified using beads coupled to protein G. The DNA was isolated from the complexes using a combination of heat to reverse cross-linking, RNase and proteases, and then purified using phenol extraction and EtOH precipitation. The final ChIP DNAs were then used as templates for Q-PCR reactions using primer pairs specific for each genomic region of interest. Q-PCR was carried out using <italic>Taq</italic> polymerase (iQ SYBR Green Supermix, Bio-Rad). Primer pairs were designed using Primer 3 [<xref ref-type="bibr" rid="B42">42</xref>]. Details of the primer sequences and the Genebank accession numbers are given in Table <xref ref-type="table" rid="T1">1</xref>. The designed primers shared 100% homology with the target sequence but no significant homology with other sequences.</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>PRIMERS FOR CHIP/Q-PCR</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left">SYMBOL</td><td align="left">DESCRIPTION</td><td align="center">MOUSE REF</td><td align="center">FORWARD PRIMER</td><td align="center">REVERSE PRIMER</td></tr></thead><tbody><tr><td align="left">Cyclin D1</td><td align="left">Cyclin D1</td><td align="left">NM_007631</td><td align="left">agagcttagggctcgtctgg</td><td align="left">agcgtccctgtcttctttca</td></tr><tr><td align="left">Ctsk</td><td align="left">Cathepsin K</td><td align="left">NM_007802</td><td align="left">atgttgaggggacagaggtg</td><td align="left">gcttctgggcatggagtagt</td></tr><tr><td align="left">Eif4ebp2</td><td align="left">eukaryotic translation initiation factor 4E</td><td align="left">NM_010124</td><td align="left">gctccacccttcaacacttc</td><td align="left">gggagggacaatatggaagc</td></tr><tr><td align="left">Wt1</td><td align="left">Wilms tumor homolog</td><td align="left">NM_144783</td><td align="left">gccagagaggagggtgtctc</td><td align="left">ATTCACACAgcagccctagc</td></tr><tr><td align="left">Serpine1</td><td align="left">serine (or cysteine) proteinase inhibitor, clade</td><td align="left">NM_008871</td><td align="left">ttccggctcacatctggtat</td><td align="left">ATTGGCTCTTGTTGGCTGTC</td></tr><tr><td align="left">Igf1r</td><td align="left">insulin-like growth factor I receptor</td><td align="left">NM_010513</td><td align="left">aaagtgccttgcgtagcagt</td><td align="left">tttcgcagtgtggtggaaag</td></tr><tr><td align="left">E-Cadherin</td><td align="left">cadherin 1</td><td align="left">NM_009864</td><td align="left">tcgggagactgaaacaggag</td><td align="left">agagggtcttgggattgcat</td></tr></tbody></table></table-wrap><p>Q-PCRs reactions were run in triplicate and the averaged Ct values were transferred into copy numbers of DNA using a standard curve of genomic DNA with known copy numbers. The resulting TFEB binding values for each genomic region were also normalized for primer pair amplification efficiency using the Q-PCR values obtained with Input DNA (unprecipitated genomic DNA). Results are presented as binding events detected per 1000 cells for each genomic region tested and compared to an untranscribed region used as a negative control. The difference between two mean values was analyzed with an unpaired Student's <italic>t</italic>-test (GraphPad Prism software version 4.0; GraphPad Software, Inc. San Diego, CA). A nominal <italic>p </italic>value less than 0.05 was considered statistically significant.</p></sec><sec sec-type="materials"><title>Materials</title><p>PAR1-AP, PAR2-AP, and PAR4-AP and control peptide were synthesized at the Molecular Biology Resource Facility, William K. Warren Medical Research Institute, OUHSC, as carboxyl-terminal amides, purified by high-pressure liquid chromatography, and characterized by mass spectroscopy. Peptide solutions were made fresh in PBS from powder. PAR3-AP was not used in this research because of lack of specificity.</p></sec></sec></sec><sec><title>Results</title><sec><title>Protein/DNA combo array</title><p>PAR1-activating peptide (AP), PAR2-AP, PAR4-AP, and control peptide were instilled into the mouse bladder at the concentration of 10 &#x003bc;M. This treatment induces a strong and reproducible bladder inflammation, whereas no inflammation was observed in mice instilled with 10 &#x003bc;M control peptide [<xref ref-type="bibr" rid="B22">22</xref>]. We used a protein/DNA combo array that separated bound DNA/protein complexes from unbound probe. The biotin-labeled probe/protein was hybridized to a membrane containing 345 transcription factor consensus sequences. As this assay closely resembles the membrane cDNA arrays, we used the same methodology developed by our collaborator (ID) to analyze the results [<xref ref-type="bibr" rid="B27">27</xref>,<xref ref-type="bibr" rid="B35">35</xref>,<xref ref-type="bibr" rid="B43">43</xref>]. Figure <xref ref-type="fig" rid="F2">2</xref> illustrates the TFs that were at least 3-fold up-regulated and Figure <xref ref-type="fig" rid="F3">3</xref> represents those TFs that were 3-fold down-regulated by each PAR-AP. Table <xref ref-type="table" rid="T2">2</xref> summarizes all TFs. The relative magnitude of the different TF signals between PAR-APs is illustrated in Figure <xref ref-type="fig" rid="F4">4</xref>. These results strongly suggested that TFEB, a member of the MiTF family of bHLH-Zip transcription factors, was the only TF commonly altered by PAR1-AP, PAR2-AP, and PAR4-AP and therefore, occupied the center of Venn diagram (Figure <xref ref-type="fig" rid="F2">2</xref>).</p><fig position="float" id="F2"><label>Figure 2</label><caption><p><bold>Up-regulated TFs downstream of PAR activation</bold>. C57BL/6 mice were instilled on two consecutive days, with 200 &#x003bc;l of a 10 &#x003bc;M solution of the PAR1-AP, PAR2-AP, PAR4-AP, or control peptide. Twenty four hours after instillation, the bladders were removed, placed on ice with peptidase inhibitors, and the urothelium/submucosa was isolated. Nuclear extracts from the bladder mucosa were analyzed by protein/DNA combo arrays containing 345 unique consensus-binding sequences per array [34]. TF expression was normalized to its own background (defined by adjusting a mean = 0 and SD = 1 of the distribution of non-expressed TFs). For further analysis, data obtained after normalization of each profile to its own background were log-transformed with substitution of negative values by the minimal logarithmic value obtained within positive values. Next, a robust regression analysis was conducted on expressed TFs and only TF with a ratio &#x0003e; 3.0 between PAR and control are represented.</p></caption><graphic xlink:href="1471-2172-8-17-2"/></fig><fig position="float" id="F3"><label>Figure 3</label><caption><p><bold>Down-regulated TFs downstream of PAR activation</bold>. Down-regulated TFs were calculated as described in Figure 2 and only TF with a ratio &#x0003c; 3.0 between PAR and control peptide are represented.</p></caption><graphic xlink:href="1471-2172-8-17-3"/></fig><fig position="float" id="F4"><label>Figure 4</label><caption><p><bold>Relative expression of TFs in response to PAR1, PAR2, and PAR4 activation</bold>. Both up- and down-regulated transcription factors altered by a factor greater than 3 are represented. Listed TFs are summarized on Table 2.</p></caption><graphic xlink:href="1471-2172-8-17-4"/></fig><table-wrap position="float" id="T2"><label>Table 2</label><caption><p>Transcriptional Factors altered by PAR-AP stimulation of the mouse bladder mucosa as detected by Protein/DNA combo array.</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left"><bold>Upregulated</bold></td><td></td></tr></thead><tbody><tr><td align="left">AP-1</td><td align="left">Fos, FosB, Fra1, Fra2, Jun, JunB [82]</td></tr><tr><td align="left">AP-2</td><td align="left">Activator protein 2 [83]</td></tr><tr><td align="left">Brn-3</td><td align="left">POU4F1: POU domain, class 4, transcription factor 1 [84]</td></tr><tr><td align="left">GAS/ISRE</td><td align="left">Gamma-interferon activation site [85]</td></tr><tr><td align="left">GATA-3</td><td align="left">GATA binding protein3 (globin transcription factor 3) [86]</td></tr><tr><td align="left">HNF-4</td><td align="left">Hepatocyte nuclear factor 4 [87]</td></tr><tr><td align="left">HOX4C</td><td align="left">homeo box4C [88]</td></tr><tr><td align="left">Oct-1</td><td align="left">POU2F1: POU domain, class 2, transcription factor 1 [89]</td></tr><tr><td align="left">p53</td><td align="left">TP53: tumor protein p53 [90]</td></tr><tr><td align="left">PBX1</td><td align="left">pre-B-cell leukemia transcription factor 1 [91]</td></tr><tr><td align="left">PTF1</td><td align="left">pancreas specific transcription factor [92]</td></tr><tr><td align="left">RORE</td><td align="left">RAR-related orphan receptor [93]</td></tr><tr><td align="left">Tax/CREB</td><td align="left">TAX &#x00026; CREB complex-responsive protein [94]</td></tr><tr><td align="left">TFEB</td><td align="left">TFEB is a the b-HLH-LZ closely related to TFE3 [38]</td></tr><tr><td align="left">Thy-1 BP</td><td align="left">Thy-1binding protein [38]</td></tr><tr><td colspan="2"><hr></hr></td></tr><tr><td align="left"><bold>Down Regulated</bold></td><td></td></tr><tr><td colspan="2"><hr></hr></td></tr><tr><td align="left">AIC, CBF</td><td align="left">Apolipoprotein AI (ApoAI) promoter c region, CCAAT-binding factor ([95]</td></tr><tr><td align="left">ARP</td><td align="left">COUP-beta; apolipoprotein AI; NR2F2 ([95]</td></tr><tr><td align="left">ATF/CRE</td><td align="left">Activating transcription factor [96]</td></tr><tr><td align="left">CREB2</td><td align="left">cyclic AMP response element binding protein 2 [97]</td></tr><tr><td align="left">Fra-1/JUN</td><td align="left">Fos-related antigen [98]</td></tr><tr><td align="left">Freac-7</td><td align="left">Forkhead box L1 [99]</td></tr><tr><td align="left">Gfi-1</td><td align="left">Growth factor independent 1 [100]</td></tr><tr><td align="left">HFH-2</td><td align="left">Forkhead box D3 [101]</td></tr><tr><td align="left">HNF-1A</td><td align="left">Hepatocyte nuclear factor 1 [102]</td></tr><tr><td align="left">HOXD9</td><td align="left">HOXD9,10 [88]</td></tr><tr><td align="left">HSE</td><td align="left">Heat shock transcription factor [103]</td></tr><tr><td align="left">kBF-A</td><td align="left">kappa immunoglobulin enhancer binding protein [104]</td></tr><tr><td align="left">Lactoferrin BP</td><td align="left">Lactoferrin enhancer binding region for estrogen receptor [105]</td></tr><tr><td align="left">LF-A2</td><td align="left">Liver-specific transcription factor [106]</td></tr><tr><td align="left">LXRE1</td><td align="left">Nuclear receptor subfamily 1, group H, member 2 [107]</td></tr><tr><td align="left">MTF</td><td align="left">MRE-binding transcription factor-1 [108]</td></tr><tr><td align="left">NF-1</td><td align="left">CTF; NF-I; TGGCA-binding protein [109]</td></tr><tr><td align="left">Pax2</td><td align="left">Pax-2 DNA-binding transcription factor [110]</td></tr><tr><td align="left">Pax5</td><td align="left">Pax-5 DNA-binding transcription factor [111]</td></tr><tr><td align="left">Snail</td><td align="left">Zinc-finger transcription factor Snail [112]</td></tr><tr><td align="left">T3R</td><td align="left">c-ErbA; thyroid hormone receptor [113]</td></tr><tr><td align="left">TEF1</td><td align="left">TEF 1 box [114]</td></tr><tr><td align="left">WAPBP</td><td align="left">Whey acidic protein binding protein [115]</td></tr></tbody></table></table-wrap></sec><sec><title>Immunohistochemistry</title><p>To confirm whether the urinary bladder expresses TFEB, we used a commercially available antibody to localize its expression. Figure <xref ref-type="fig" rid="F5">5A&#x02013;B</xref> represents the expected morphology of the urinary bladder in a cross-section. Figure <xref ref-type="fig" rid="F5">5A</xref> is a composite of 18 H&#x00026;E stained photomicrographs of the same cross-section at low magnification (&#x000d7;100), and illustrates the localization of the different layers: urothelium and submucosa, as well as the detrusor muscle. Figure <xref ref-type="fig" rid="F5">5B</xref> is a high magnification of the mouse bladder urothelium showing a multi-layered urothelium with apical umbrella cells (arrow). Figure <xref ref-type="fig" rid="F6">6</xref> is a representative image of a bladder isolated from a mouse challenged with PAR2-AP (10 &#x003bc;M), which indicates the expression of TFEB, particularly in the nucleus (DAPI-positive) of the urothelial cells. Figure <xref ref-type="fig" rid="F7">7</xref> is a representative photomicrograph of the mouse bladder stained with secondary antibody. Figures <xref ref-type="fig" rid="F8">8A&#x02013;I</xref> are representative photomicrographs illustrating TFEB expression in the bladder cross sections. Figures <xref ref-type="fig" rid="F8">8A&#x02013;C</xref> show the constitutive expression of TFEB in the urinary bladders isolated from mice stimulated with the control peptide, including the urothelium (Figures <xref ref-type="fig" rid="F8">8A&#x02013;C</xref>) and detrusor muscle. A higher magnification insert depicts the expression in the smooth muscle (Figure <xref ref-type="fig" rid="F8">8B</xref>). Figures <xref ref-type="fig" rid="F8">8D</xref> and <xref ref-type="fig" rid="F8">8E</xref> are representative images of tissues isolated from PAR1-AP-treated mice and illustrate an overwhelming TFEB expression throughout the urothelial layer, including umbrella cells (Figure <xref ref-type="fig" rid="F8">8E</xref>). Figures <xref ref-type="fig" rid="F8">8F&#x02013;G</xref> and <xref ref-type="fig" rid="F8">8H&#x02013;I</xref> are representative of responses to PAR2-AP and PAR4-AP, respectively. Overall, our results indicate a constitutive, although low, expression of TFEB in the control bladder urothelium. Bladder instillation with PAR-APs induced a substantial induction of TFEB expression, primarily in the urothelium, that was clearly observed in response to PAR2-AP and PAR4-AP, and to a lesser extent, with PAR1-AP. Figure <xref ref-type="fig" rid="F9">9</xref> presents the quantification of 3 replications of TFEB immunohistochemistry.</p><fig position="float" id="F5"><label>Figure 5</label><caption><p>Representative photomicrograph of the expected morphology of the urinary bladder in a cross-section. Figure 5A is a composite of 18 H&#x00026;E stained photomicrographs of the same cross-section at original magnification of 100&#x000d7; and illustrates the localization of the different layers: urothelium and submucosa, as well as the detrusor muscle. Black wavy line indicates the urothelium/submucosal layer. Figure 5B is a high magnification of the mouse bladder urothelium showing a multi-layered urothelium with apical umbrella cells (yellow arrow).</p></caption><graphic xlink:href="1471-2172-8-17-5"/></fig><fig position="float" id="F6"><label>Figure 6</label><caption><p>Representative photomicrograph of the bladder urothelium isolated from a C57BL/6 mouse challenged with PAR2-AP (10 &#x003bc;M). White circle indicates the expression of TFEB, particularly in the nucleus (DAPI-positive) of the urothelial cells.</p></caption><graphic xlink:href="1471-2172-8-17-6"/></fig><fig position="float" id="F7"><label>Figure 7</label><caption><p>Representative photomicrograph of the mouse bladder urothelium isolated and stained with DAPI and secondary antibody.</p></caption><graphic xlink:href="1471-2172-8-17-7"/></fig><fig position="float" id="F8"><label>Figure 8</label><caption><p>Representative photomicrographs illustrating a constitutive TFEB expression in the urothelium (8 A-C) and smooth muscle 8A of C57BL/6 mice stimulated with control peptide. The insert, Figure 8B is a high magnification of the area highlighted in Figure 8A. Figures 8D and 8E are representative images of tissues isolated from PAR1-AP-treated C57BL/6 mice and illustrate an overwhelming TFEB expression throughout the urothelial layer, including in umbrella cells (green arrow, Figure 8E). Figures 8 F-G and 8 H-I are representative of responses to PAR2-AP and PAR4-AP, respectively. Yellow arrow indicates the urothelium (8C) and dotted white circle indicate TFEB positive cells in the detrusor smooth muscle (Figures 8A and 8B).</p></caption><graphic xlink:href="1471-2172-8-17-8"/></fig><fig position="float" id="F9"><label>Figure 9</label><caption><p>Quantification of 3 replications of TFEB Immunohistochemistry. Asterisks indicate a statistically significant difference (p &#x0003c; 0.05) between PAR-APs and control peptide in inducing TFEB immuno stain.</p></caption><graphic xlink:href="1471-2172-8-17-9"/></fig></sec><sec><title>Absence of PAR-induced bladder inflammation in <italic>c-kit</italic>-deficient mice</title><p>Direct evidence for an essential role for mast cells in cystitis was reported by our laboratory in animal models of bladder inflammation [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B44">44</xref>]. However, the responses to PAR-APs were not investigated. Therefore, we compared the bladder inflammatory responses to PAR1-AP in wild type and Kit<sup>w</sup>/Kit<sup>w-v </sup>mice. As shown in Figure <xref ref-type="fig" rid="F10">10</xref>, PAR1-AP induces inflammation in wild type mice, consistent with our previous published results [<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B22">22</xref>]. This inflammation was characterized by intense inflammatory infiltrate in the submucosa and vasodilation (Figure <xref ref-type="fig" rid="F10">10A</xref>). In contrast, Kit<sup>w</sup>/Kit<sup>w-v </sup>did not develop an inflammatory response to PAR1 activation (Figure <xref ref-type="fig" rid="F10">10B</xref>).</p><fig position="float" id="F10"><label>Figure 10</label><caption><p>Comparison of bladder inflammation in response to 10 &#x003bc;M of PAR1-AP in wild type (C57BL/6) and c-kit receptor deficient (Kit<sup>w</sup>/Kit<sup>w-v</sup>) mice. A = Representative photomicrographs of H&#x00026;E stained C57BL/6 urinary bladders following PAR1-AP (10 &#x003bc;M)-induced inflammation. PAR1-induced inflammation was characterized in C57BL/6 mice by an intense vasodilation (yellow arrows) and polymorphonuclear leukocyte infiltration (black arrows). B = absence of bladder inflammation in bladders isolated from Kit<sup>w</sup>/Kit<sup>w-v </sup>mice challenged with PAR1-AP.</p></caption><graphic xlink:href="1471-2172-8-17-10"/></fig></sec><sec><title>Electrophoretic mobility shift assay (EMSA)</title><p>We used the same binding sequence present in the Panomics array [<xref ref-type="bibr" rid="B34">34</xref>], as the TFEB EMSA probe. Our results indicate that intravesical instillation of C57BL/6 mice with all PAR-APs increased the binding activity to the TFEB probe primarily in extracts of the bladder mucosa (Figure <xref ref-type="fig" rid="F11">11A</xref>). In contrast, no significant increase was observed in mast cell deficient Kit<sup>w</sup>/Kit<sup>w-v </sup>mice challenged with PAR1-AP (Figure <xref ref-type="fig" rid="F11">11C</xref>). In addition to TFEB, other members of the microphthalmia (MiTF)-TFE subfamily of basic helix-loop-helix leucine zipper (bHLH-ZIP) transcription factors are known to bind to this E-Box sequence [<xref ref-type="bibr" rid="B45">45</xref>-<xref ref-type="bibr" rid="B47">47</xref>]. Therefore, we used a TFEB antibody to reveal a specific TFEB activity, as illustrated by the super shift bands in tissues isolated from C57BL/6 (Figure <xref ref-type="fig" rid="F11">11B</xref>) and Kit<sup>w</sup>/Kit<sup>w-v </sup>mice (Figure <xref ref-type="fig" rid="F11">11D</xref>). Next, we determined the variability of the EMSA by performing additional experiments in tissues isolated from C57BL/6 mice that were challenged with the control peptide and PAR1-AP (10 &#x003bc;M), Figure <xref ref-type="fig" rid="F12">12</xref>. ImageJ software was used to quantify the EMSA signals and the integrated density is presented on Figures <xref ref-type="fig" rid="F13">13A&#x02013;C</xref></p><fig position="float" id="F11"><label>Figure 11</label><caption><p><bold>Electrophoretic mobility shift (EMSA) and gel shift assays</bold>. A) EMSA was performed with C57BL/6 mice treated intravesically with control peptide, PAR1-AP, PAR2-AP, or PAR4-AP, at a concentration of 10 &#x003bc;M. Following treatment, the bladders were removed and the urothelium/submucosa was separated from the detrusor smooth muscle, and nuclear extracts were obtained from both layers. Shifted bands were observed with all treatments. C) No significant increase was observed in mast cell deficient Kit<sup>w</sup>/Kit<sup>w-v </sup>mice challenged with PAR1-AP. For super-shift assays (B and D), reactions were incubated for 30 minutes at 4&#x000b0;C with TFEB antibody, prior to addition of the probe.</p></caption><graphic xlink:href="1471-2172-8-17-11"/></fig><fig position="float" id="F12"><label>Figure 12</label><caption><p>Additional TFEB EMSA performed in tissues isolated from C57BL/6 mice that were challenged with the control peptide and PAR1-AP (10 &#x003bc;M).</p></caption><graphic xlink:href="1471-2172-8-17-12"/></fig><fig position="float" id="F13"><label>Figure 13</label><caption><p><bold>Quantification of EMSA results</bold>. Graphical representation of the integrated density for TEFB EMSAs in bladder mucosa (A) and detrusor muscle (B) isolated from C57BL/6 mice treated with the control peptide, PAR1-AP, PAR2-AP, and PAR4-AP, and tissues isolated from kit<sup>w</sup>/kit<sup>w-v </sup>mice challenged the control peptide and PAR1-AP (C). Asterisks indicate a statistically significant difference (p &#x0003c; 0.05) between PAR-APs and control peptide in inducing an increase in TFEB binding activity.</p></caption><graphic xlink:href="1471-2172-8-17-13"/></fig></sec><sec><title>Target validation by Q-PCR of Chromatin Immunoprecipitation (CHIP)-Based Assays</title><p>In order to investigate whether the increased expression of TFEB would translate into an up-regulation of genes known to contain an E-box on their promoter, we used a combination of chromatin immunopreciptation (CHIP) and real-time polymerase chain (Q-PCR). For this purpose, we used the same TFEB antibody employed for IHC. CHIP was obtained from the whole bladder isolated from PAR2-AP- and control peptide-treated bladders. We queried the expression of selected genes known to have an E-box on their promoter and compared the results with an un-transcribed region of the DNA. Figure <xref ref-type="fig" rid="F14">14</xref> indicates an increased number of events (p &#x0003c; 0.05) on the CHIP precipitated with TFEB antibody when compared to the un-transcribed region for the following genes: e-cadherin, eif4bp2, serpine 1, IGF1R, and cyclin D1. In addition, inflammation associated with PAR2 stimulation led to an up-regulation of serpine 1, WT1, cyclin D1, IGF1R, and cathepsin K.</p><fig position="float" id="F14"><label>Figure 14</label><caption><p><bold>Target validation by Q-PCR of Chromatin Immunoprecipitation (CHIP)-Based Assays</bold>. Female C57BL/6J mice were anesthetized and instilled with 200 &#x003bc;l of control peptide or PAR2-AP on days 1 and 2, as described in methods. Mice were euthanized 24 hours after the last instillation; the urinary bladders were removed rapidly, frozen, and shipped to Genpathway [40] for querying the chromatin for transcription of selected genes. After isolation, the chromatin was incubated with TFEB antibody to precipitate the CHIP DNA. The final CHIP DNAs were then used as templates in Q-PCR reactions, performed in triplicate, using specific primer pairs (Table 1). Results are presented as average and standard error of Transcription Binding Events Detected Per 1000 Cells. Asterisks indicate a statistical significant difference (p &#x0003c; 0.05) between a specific gene and the un-transcribed region used as control and a plus sign indicates a statistical significant difference (p &#x0003c; 0.05) between CHIPs isolated from PAR2-AP- and control peptide-treated bladders.</p></caption><graphic xlink:href="1471-2172-8-17-14"/></fig></sec></sec><sec><title>Discussion</title><p>We used a top-down approach for determination of transcription factors involved in the response of the mouse bladder to pro-inflammatory PAR-APs (Figure <xref ref-type="fig" rid="F1">1</xref>). First, a Protein/DNA combo array was used to select transcription factors common to all PAR activation. Out of 345 TFs present in this array, only TFEB was shared by PAR1-, PAR2-, and PAR4 activation. Next, we confirmed that TFEB is expressed in the mouse bladder by IHC. Finally, we compared the inflammatory responses to PAR1-AP between wild type and mast cell-deficient Kit<sup>w</sup>/Kit<sup>w-v </sup>mice. Kit<sup>w</sup>/Kit<sup>w-v </sup>mice failed to mount an inflammatory response to PAR1-AP, and EMSA confirmed that TFEB is upregulated by all PAR-APs in wild type mice but not in Kit<sup>w</sup>/Kit<sup>w-v </sup>mice. Finally, we used a combination of chromatin immunoprecipitation and QPCR to target validate transcripts known to be under the control of TFEB. This assay takes into consideration genes that are actively transcribed, in contrast to cDNA array technologies that queries RNA accumulation. The disadvantage of the CHIP/Q-PCR method is the amount of chromatin necessary for CHIP, which limits this analysis to the whole bladder and not to specific layers (mucosa and detrusor) used for EMSA. Therefore, our CHIP/Q-PCR results have to be taken in the context that migrating inflammatory cells, in addition to resident cells, contributed to the measured values. These results indicate that TFEB is downstream of PAR activation, that this response occurs primarily in the bladder urothelium, and that TFEB mobilization depends on the presence of either mast cells or alternatively c-kit receptors, which are expressed on a variety of tissues, including certain nerves. Given our previous findings demonstrating the importance of mast cells in bladder inflammation and our finding of MiTF expression, we speculate that the mast cell is the key contributor to this response, but further studies will be necessary to delineate the precise mechanism of TFEB mobilization.</p><p>TFEB belongs to the microphthalmia (MiTF)-TFE subfamily of basic helix-loop-helix leucine zipper (bHLH-ZIP) transcription factors which includes four family members: TFEB, TFE3, TFEC, and MiTF. MiTF family members are required for the proper development of osteoclasts, melanocytes, retinal pigment epithelial cells, mast cells, and natural killer cells [<xref ref-type="bibr" rid="B48">48</xref>]. In addition, MiTF has been implicated in the regulation of tissue-specific gene expression in mast cells [<xref ref-type="bibr" rid="B49">49</xref>].</p><p>Each protein of the MiTF family forms homo- or heterodimers with other family members [<xref ref-type="bibr" rid="B50">50</xref>] and recognizes, in general, the same DNA sequences [<xref ref-type="bibr" rid="B51">51</xref>]. In particular, TFE3 and TFEB elicit their effects mainly through the binding to M-box (AGTCATGTGCT) and E-box motifs (CACGTG) [<xref ref-type="bibr" rid="B52">52</xref>].</p><sec><title>MiTF family in the urinary tract</title><p>The only other finding implicating this family in the urinary tract is their involvement in renal cell carcinoma. In this regard, TFE3 is involved in chromosomal translocations recurrent in renal cell carcinoma [<xref ref-type="bibr" rid="B53">53</xref>]. Translocations of the genes encoding the related transcription factors TFE3 and TFEB are almost exclusively associated with a rare juvenile subset of renal cell carcinoma and lead to over-expression of TFE3 or TFEB protein sequences. TFE3 and TFEB have been identified as cell type-specific leukemia inhibitory factor-responsive activators of E-cadherin [<xref ref-type="bibr" rid="B54">54</xref>].</p></sec><sec><title>MiTF and Mast Cells</title><p>MiTF mRNA and protein levels are higher in human mast cells than monocytes and granulocytes [<xref ref-type="bibr" rid="B55">55</xref>]. MiTF seems to be involved in the migration, phenotypic expression, and survival of mast cells [<xref ref-type="bibr" rid="B56">56</xref>]. As an essential transcriptional effector of the c-kit pathway, MiTF is critical for mast cell [<xref ref-type="bibr" rid="B49">49</xref>,<xref ref-type="bibr" rid="B56">56</xref>] and melanocyte development [<xref ref-type="bibr" rid="B49">49</xref>,<xref ref-type="bibr" rid="B57">57</xref>-<xref ref-type="bibr" rid="B59">59</xref>]. Mice deficient in MiTF harbor a severe mast cell deficiency, and MiTF-mutant mast cells cultured <italic>ex vivo </italic>display a number of functional defects [<xref ref-type="bibr" rid="B60">60</xref>]. In addition, <italic>c-kit</italic>- and m-Csf-dependent MAPK phosphorylation transcriptionally activates both TFE3 and MiTF, which is necessary for mast cell developmental functions [<xref ref-type="bibr" rid="B54">54</xref>]. Our findings indicate that the bladder inflammatory responses mediated by PAR1 are dependent on the presence of mast cells by a mechanism that involves TFEB. The latter adds to a list of evidence published by this laboratory indicating that Kit<sup>w</sup>/Kit<sup>w-v </sup>mice do not develop bladder inflammation in response to antigen challenge [<xref ref-type="bibr" rid="B7">7</xref>], and substance P [<xref ref-type="bibr" rid="B7">7</xref>] stimulation, whereas reconstitution Kit<sup>w</sup>/Kit<sup>w-v </sup>with mast cells from wild type mice restores the inflammatory response [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B8">8</xref>]. Therefore, we did not test whether the responses mediated by PAR2 and PAR4 are also dependent on the presence of mast cells.</p></sec><sec><title>PARs and MiTF</title><p>Thrombin and tryptase are endogenous agonists of PARs in humans. Along with serine proteases, it seems that tissue factor and element of the coagulation cascade are also endogenous activators of PARs [<xref ref-type="bibr" rid="B61">61</xref>,<xref ref-type="bibr" rid="B62">62</xref>]. In human vascular endothelial cells both thrombin and PAR1-AP elicited gene regulation via E-box signaling [<xref ref-type="bibr" rid="B62">62</xref>]. However, the information regarding endogenous activators of PARs in the mouse bladder is, unfortunately, scanty. While human connective tissue mast cells contain the enzymes chymase and tryptase, mice contain numerous related proteases [<xref ref-type="bibr" rid="B63">63</xref>-<xref ref-type="bibr" rid="B65">65</xref>]. Mouse mast cell protease-7 is a tryptase predominantly expressed in differentiated connective tissue-type mast cells [<xref ref-type="bibr" rid="B66">66</xref>]. Mast cell proteases mcpt-5 (chymase), and the tryptases mcpt-6 and mcpt-7 are all expressed during the development of the mouse embryo [<xref ref-type="bibr" rid="B63">63</xref>]. However, to the best of our knowledge, there is no information regarding which particular tryptase is expressed in the mouse bladder and/or upregulated in the mouse model during inflammation. Although thrombin is a recognized physiological activator of PAR1 and PAR4, the endogenous enzymes responsible for activating PAR2 in urinary bladder are not known. Recently, it was demonstrated that the kallikrein family of proteinases are able to regulate PAR signaling and may represent important endogenous regulators PAR1, PAR2, and PAR4 [<xref ref-type="bibr" rid="B67">67</xref>]. The latter are likely to be confirmed in the urinary tract, since members of the kallikrein family play a fundamental role in bladder physiology [<xref ref-type="bibr" rid="B68">68</xref>]. It is interesting to note that activation of PARs on the bladder urothelium leads to activation of one of the members of the MiTF family. Others have shown that mast cell tryptase and MiTF are highly sensitive and specific markers for mast cell disease [<xref ref-type="bibr" rid="B69">69</xref>]. Moreover, MiTF regulates the expression of mouse tryptases, such as mcpt-7 [<xref ref-type="bibr" rid="B70">70</xref>] and mcpt-6, in response to stem cell factor [<xref ref-type="bibr" rid="B64">64</xref>] or transforming growth factor-beta stimulation [<xref ref-type="bibr" rid="B71">71</xref>].</p></sec><sec><title>Involvement of mast cells and PARs in bladder inflammation</title><p>Mast cells are strategically located for optimal interaction with the environment and for their putative functions in host defense [<xref ref-type="bibr" rid="B72">72</xref>]. Among the mast cell mediators, tryptase is expressed by most human mast cells comprising as much as 25% of the cells' protein [<xref ref-type="bibr" rid="B73">73</xref>], and it is released in response to inflammatory stimuli [<xref ref-type="bibr" rid="B73">73</xref>,<xref ref-type="bibr" rid="B74">74</xref>]. Indirect evidence for a role of mast cells in cystitis was reviewed in Ref. [<xref ref-type="bibr" rid="B75">75</xref>] and includes increased concentration of tryptase in the urine of interstitial cystitis (IC) patients [<xref ref-type="bibr" rid="B9">9</xref>], presence of mast cells containing tryptase in the bladder of IC patients [<xref ref-type="bibr" rid="B75">75</xref>,<xref ref-type="bibr" rid="B76">76</xref>], and that mast cell counts in IC patients are one of the few features significantly associated with night-time frequency (p &#x0003c; 0.01; ref. [<xref ref-type="bibr" rid="B77">77</xref>]). We published direct evidence that mast cells are essential for both bladder inflammation and gene-regulation in experimental cystitis [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B8">8</xref>]. Our publications show that bladder inflammation is induced in normal mice and not in mast cell-deficient Kit<sup>w</sup>/Kit<sup>w-v </sup>mice. The differences observed were abolished when Kit<sup>w</sup>/Kit<sup>w-v </sup>mice had their mast cell deficiency selectively repaired by transplantation of bone marrow-derived mast cells from the normal congenic +/+ mice [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B8">8</xref>]. As the bladder response in these mice is similar to the normal +/+ mice, we concluded that mast cells are essential for the development of cystitis [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B8">8</xref>].</p><p>PARs provide an answer to the question of how mast cell products, such as tryptase, produce signals and induce bladder inflammation. Recently, we characterized the bladder responses to PAR-APs and presented evidence of a mandatory role for PARs in experimental cystitis [<xref ref-type="bibr" rid="B22">22</xref>]. We went further to determine the regulatory network downstream of PARs [<xref ref-type="bibr" rid="B25">25</xref>]. Our present findings further emphasize that products of mast cells such as tryptase inducing activation of PARs can lead to increased activity of transcription factors such as TFEB that play a fundamental role in mast cell survival. This positive feedback loop might be responsible for the mast cell-dependent perpetuation of bladder inflammation. However, the precise mechanisms involved in this feed back remain to be determined. One possibility is that the mast cells themselves express PARs and are susceptible to PAR-AP activation [<xref ref-type="bibr" rid="B78">78</xref>,<xref ref-type="bibr" rid="B79">79</xref>]. Indeed, PAR1-AP induces mast cell adhesion to fibronectin [<xref ref-type="bibr" rid="B79">79</xref>]. In contrast, messenger RNA for PAR-1 was detected in peritoneal mast cells [<xref ref-type="bibr" rid="B80">80</xref>], but PAR-APs failed to induce histamine release from these cells [<xref ref-type="bibr" rid="B80">80</xref>]. Another possibility is that inflammatory mediators can modulate the mast cell sensitivity to PAR-APs. Indeed, inflammatory cytokines such as IL-4 and IL-12 were suggested to regulate PAR receptor expression on the mast cells [<xref ref-type="bibr" rid="B81">81</xref>].</p></sec></sec><sec><title>Conclusion</title><p>To the best of our knowledge, this is the first report describing TFEB expression in response to PAR activation in the bladder and suggest a unifying, mechanistic pathway of bladder inflammation as follows: we hypothesize that mast cells release tryptase resulting in increased PAR activation and, consequently, TFEB/MiTF activity. As a result of increased of MiTF activity in mast cells there is mMCP-6 and mMCP-7 synthesis, leading to additional signals for inflammation. The findings that TFEB is downstream of activation of all PARs, makes this transcriptional factor a novel therapeutic target for the treatment of inflammatory disorders of the bladder.</p></sec><sec><title>Abbreviations</title><p>CHIP, chromatin immunoprecipitation; IHC, immunohistochemistry; PAR, protease-activated receptors; PAR-AP, protease-activated receptor-activating peptide; Q-PCR = real-time polymerase chain; TF, transcription factor.</p></sec><sec><title>Competing interests</title><p>The authors declare that they have no competing interests.</p></sec><sec><title>Authors' contributions</title><p>All authors read and approved the final manuscript. <bold>RS </bold>conceived of the study and drafted the manuscript; <bold>JM </bold>participated on the design of immunohistochemistry protocols and choice of antibodies, performed the immunohistochemistry and confocal microscopy analysis; <bold>BF </bold>participated on the design of confocal experiments; <bold>CAD </bold>maintained the genotyping and animal colony; <bold>CS </bold>helped <bold>MRS </bold>with animal experiments, performed protein/DNA combo array, EMSAs, and gel shift assays, <bold>ID </bold>performed the statistical analysis of protein/DNA combo array, <bold>MI </bold>participated in its design and helped to draft the manuscript, <bold>REH </bold>participated in its design and helped to draft the manuscript, <bold>BW </bold>consulted <bold>RS </bold>regarding the participation of mast cells, <bold>MRS </bold>participated in its design, carried out all the animal experiments, and removed the tissues.</p></sec></body><back><ack><sec><title>Acknowledgements</title><p>This work was supported by National Institutes of Health Grants DK 55828-01 and DK066101-01 (R.S.).</p></sec></ack><ref-list><ref id="B1"><citation citation-type="other"><article-title>NIH Roadmap for Medical Research</article-title><ext-link ext-link-type="uri" xlink:href="http://nihroadmap.nih.gov/2008initiatives.asp"/></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hilmy</surname><given-names>M</given-names></name><name><surname>Campbell</surname><given-names>R</given-names></name><name><surname>Bartlett</surname><given-names>JM</given-names></name><name><surname>McNicol</surname><given-names>AM</given-names></name><name><surname>Underwood</surname><given-names>MA</given-names></name><name><surname>McMillan</surname><given-names>DC</given-names></name></person-group><article-title>The relationship between the systemic inflammatory response, tumour proliferative activity, T-lymphocytic infiltration and COX-2 expression and survival in patients with transitional cell carcinoma of the urinary bladder</article-title><source>Br J Cancer</source><year>2006</year><volume>95</volume><fpage>1234</fpage><lpage>1238</lpage><pub-id pub-id-type="pmid">17024120</pub-id><pub-id pub-id-type="doi">10.1038/sj.bjc.6603415</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname><given-names>T</given-names></name><name><surname>Nesi</surname><given-names>G</given-names></name><name><surname>Boddi</surname><given-names>V</given-names></name><name><surname>Mazzoli</surname><given-names>S</given-names></name><name><surname>Dal Canto</surname><given-names>M</given-names></name><name><surname>Bartoletti</surname><given-names>R</given-names></name></person-group><article-title>Prognostic role of the tumor-associated tissue inflammatory reaction in transitional bladder cell carcinoma</article-title><source>Oncol Rep</source><year>2006</year><volume>16</volume><fpage>329</fpage><lpage>334</lpage><pub-id pub-id-type="pmid">16820911</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname><given-names>J</given-names></name><name><surname>Grossman</surname><given-names>HB</given-names></name><name><surname>Dinney</surname><given-names>CP</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name></person-group><article-title>The pharmacogenetic impact of inflammatory genes on bladder cancer recurrence</article-title><source>Pharmacogenomics</source><year>2005</year><volume>6</volume><fpage>575</fpage><lpage>584</lpage><pub-id pub-id-type="pmid">16142998</pub-id><pub-id pub-id-type="doi">10.2217/14622416.6.6.575</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Offersen</surname><given-names>BV</given-names></name><name><surname>Knap</surname><given-names>MM</given-names></name><name><surname>Marcussen</surname><given-names>N</given-names></name><name><surname>Horsman</surname><given-names>MR</given-names></name><name><surname>Hamilton-Dutoit</surname><given-names>S</given-names></name><name><surname>Overgaard</surname><given-names>J</given-names></name></person-group><article-title>Intense inflammation in bladder carcinoma is associated with angiogenesis and indicates good prognosis</article-title><source>Br J Cancer</source><year>2002</year><volume>87</volume><fpage>1422</fpage><lpage>1430</lpage><pub-id pub-id-type="pmid">12454772</pub-id><pub-id pub-id-type="doi">10.1038/sj.bjc.6600615</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>D'Andrea</surname><given-names>MR</given-names></name><name><surname>Saban</surname><given-names>MR</given-names></name><name><surname>Gerard</surname><given-names>NP</given-names></name><name><surname>Wershil</surname><given-names>BK</given-names></name><name><surname>Saban</surname><given-names>R</given-names></name></person-group><article-title>Lack of neurokinin-1 receptor expression affects tissue mast cell numbers but not their spatial relationship with nerves</article-title><source>Am J Physiol Regul Integr Comp Physiol</source><year>2005</year><volume>288</volume><fpage>R491</fpage><lpage>500</lpage><pub-id pub-id-type="pmid">15458971</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saban</surname><given-names>R</given-names></name><name><surname>Gerard</surname><given-names>NP</given-names></name><name><surname>Saban</surname><given-names>MR</given-names></name><name><surname>Nguyen</surname><given-names>NB</given-names></name><name><surname>DeBoer</surname><given-names>DJ</given-names></name><name><surname>Wershil</surname><given-names>BK</given-names></name></person-group><article-title>Mast cells mediate substance P-induced bladder inflammationthrough an NK(1) receptor-independent mechanism</article-title><source>Am J Physiol Renal Physiol</source><year>2002</year><volume>283</volume><fpage>F616</fpage><lpage>629</lpage><pub-id pub-id-type="pmid">12217852</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saban</surname><given-names>R</given-names></name><name><surname>Saban</surname><given-names>MR</given-names></name><name><surname>Nguyen</surname><given-names>NB</given-names></name><name><surname>Hammond</surname><given-names>TG</given-names></name><name><surname>Wershil</surname><given-names>BK</given-names></name></person-group><article-title>Mast cell regulation of inflammation and gene expression during antigen-induced bladder inflammation in mice</article-title><source>Physiol Genomics</source><year>2001</year><volume>7</volume><fpage>35</fpage><lpage>43</lpage><pub-id pub-id-type="pmid">11595790</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Okragly</surname><given-names>AJ</given-names></name><name><surname>Niles</surname><given-names>AL</given-names></name><name><surname>Saban</surname><given-names>R</given-names></name><name><surname>Schmidt</surname><given-names>D</given-names></name><name><surname>Hoffman</surname><given-names>RL</given-names></name><name><surname>Warner</surname><given-names>TF</given-names></name><name><surname>Moon</surname><given-names>TD</given-names></name><name><surname>Uehling</surname><given-names>DT</given-names></name><name><surname>Haak-Frendscho</surname><given-names>M</given-names></name></person-group><article-title>Elevated tryptase, nerve growth factor, neurotrophin-3 and glial cell line-derived neurotrophic factor levels in the urine of interstitial cystitis and bladder cancer patients</article-title><source>J Urol</source><year>1999</year><volume>161</volume><fpage>438</fpage><lpage>441</lpage><comment>discussion 441&#x02013;432.</comment><pub-id pub-id-type="pmid">9915421</pub-id><pub-id pub-id-type="doi">10.1016/S0022-5347(01)61915-3</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vergnolle</surname><given-names>N</given-names></name><name><surname>Cellars</surname><given-names>L</given-names></name><name><surname>Mencarelli</surname><given-names>A</given-names></name><name><surname>Rizzo</surname><given-names>G</given-names></name><name><surname>Swaminathan</surname><given-names>S</given-names></name><name><surname>Beck</surname><given-names>P</given-names></name><name><surname>Steinhoff</surname><given-names>M</given-names></name><name><surname>Andrade-Gordon</surname><given-names>P</given-names></name><name><surname>Bunnett</surname><given-names>NW</given-names></name><name><surname>Hollenberg</surname><given-names>MD</given-names></name><name><surname>Wallace</surname><given-names>JL</given-names></name><name><surname>Cirino</surname><given-names>G</given-names></name><name><surname>Fiorucci</surname><given-names>S</given-names></name></person-group><article-title>A role for proteinase-activated receptor-1 in inflammatory bowel diseases</article-title><source>Journal of Clinical Investigation</source><year>2004</year><volume>114</volume><fpage>1444</fpage><pub-id pub-id-type="pmid">15545995</pub-id><pub-id pub-id-type="doi">10.1172/JCI200421689</pub-id></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cenac</surname><given-names>N</given-names></name><name><surname>Garcia-Villar</surname><given-names>R</given-names></name><name><surname>Ferrier</surname><given-names>L</given-names></name><name><surname>Larauche</surname><given-names>M</given-names></name><name><surname>Vergnolle</surname><given-names>N</given-names></name><name><surname>Bunnett</surname><given-names>NW</given-names></name><name><surname>Coelho</surname><given-names>AM</given-names></name><name><surname>Fioramonti</surname><given-names>J</given-names></name><name><surname>Bueno</surname><given-names>L</given-names></name></person-group><article-title>Proteinase-activated receptor-2-induced colonic inflammation in mice: possible involvement of afferent neurons, nitric oxide, and paracellular permeability</article-title><source>J Immunol</source><year>2003</year><volume>170</volume><fpage>4296</fpage><lpage>4300</lpage><pub-id pub-id-type="pmid">12682265</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schmidlin</surname><given-names>F</given-names></name><name><surname>Amadesi</surname><given-names>S</given-names></name><name><surname>Dabbagh</surname><given-names>K</given-names></name><name><surname>Lewis</surname><given-names>DE</given-names></name><name><surname>Knott</surname><given-names>P</given-names></name><name><surname>Bunnett</surname><given-names>NW</given-names></name><name><surname>Gater</surname><given-names>PR</given-names></name><name><surname>Geppetti</surname><given-names>P</given-names></name><name><surname>Bertrand</surname><given-names>C</given-names></name><name><surname>Stevens</surname><given-names>ME</given-names></name></person-group><article-title>Protease-activated receptor 2 mediates eosinophil infiltration and hyperreactivity in allergic inflammation of the airway</article-title><source>J Immunol</source><year>2002</year><volume>169</volume><fpage>5315</fpage><lpage>5321</lpage><pub-id pub-id-type="pmid">12391252</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Steinhoff</surname><given-names>M</given-names></name><name><surname>Vergnolle</surname><given-names>N</given-names></name><name><surname>Young</surname><given-names>SH</given-names></name><name><surname>Tognetto</surname><given-names>M</given-names></name><name><surname>Amadesi</surname><given-names>S</given-names></name><name><surname>Ennes</surname><given-names>HS</given-names></name><name><surname>Trevisani</surname><given-names>M</given-names></name><name><surname>Hollenberg</surname><given-names>MD</given-names></name><name><surname>Wallace</surname><given-names>JL</given-names></name><name><surname>Caughey</surname><given-names>GH</given-names></name><name><surname>Mitchell</surname><given-names>SE</given-names></name><name><surname>Williams</surname><given-names>LM</given-names></name><name><surname>Geppetti</surname><given-names>P</given-names></name><name><surname>Mayer</surname><given-names>EA</given-names></name><name><surname>Bunnett</surname><given-names>NW</given-names></name></person-group><article-title>Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism</article-title><source>Nat Med</source><year>2000</year><volume>6</volume><fpage>151</fpage><lpage>158</lpage><pub-id pub-id-type="pmid">10655102</pub-id><pub-id pub-id-type="doi">10.1038/72247</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ossovskaya</surname><given-names>VS</given-names></name><name><surname>Bunnett</surname><given-names>NW</given-names></name></person-group><article-title>Protease-activated receptors: contribution to physiology and disease</article-title><source>Physiol Rev</source><year>2004</year><volume>84</volume><fpage>579</fpage><lpage>621</lpage><pub-id pub-id-type="pmid">15044683</pub-id><pub-id pub-id-type="doi">10.1152/physrev.00028.2003</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Amadesi</surname><given-names>S</given-names></name><name><surname>Nie</surname><given-names>J</given-names></name><name><surname>Vergnolle</surname><given-names>N</given-names></name><name><surname>Cottrell</surname><given-names>GS</given-names></name><name><surname>Grady</surname><given-names>EF</given-names></name><name><surname>Trevisani</surname><given-names>M</given-names></name><name><surname>Manni</surname><given-names>C</given-names></name><name><surname>Geppetti</surname><given-names>P</given-names></name><name><surname>McRoberts</surname><given-names>JA</given-names></name><name><surname>Ennes</surname><given-names>H</given-names></name><name><surname>Davis</surname><given-names>JB</given-names></name><name><surname>Mayer</surname><given-names>EA</given-names></name><name><surname>Bunnett</surname><given-names>NW</given-names></name></person-group><article-title>Protease-activated receptor 2 sensitizes the capsaicin receptor transient receptor potential vanilloid receptor 1 to induce hyperalgesia</article-title><source>J Neurosci</source><year>2004</year><volume>24</volume><fpage>4300</fpage><lpage>4312</lpage><pub-id pub-id-type="pmid">15128844</pub-id><pub-id pub-id-type="doi">10.1523/JNEUROSCI.5679-03.2004</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Reed</surname><given-names>DE</given-names></name><name><surname>Barajas-Lopez</surname><given-names>C</given-names></name><name><surname>Cottrell</surname><given-names>G</given-names></name><name><surname>Velazquez-Rocha</surname><given-names>S</given-names></name><name><surname>Dery</surname><given-names>O</given-names></name><name><surname>Grady</surname><given-names>EF</given-names></name><name><surname>Bunnett</surname><given-names>NW</given-names></name><name><surname>Vanner</surname><given-names>SJ</given-names></name></person-group><article-title>Mast cell tryptase and proteinase-activated receptor 2 induce hyperexcitability of guinea pig submucosal neurons</article-title><source>J Physiol</source><year>2003</year><volume>547</volume><fpage>531</fpage><lpage>542</lpage><comment>10.1113/jphysiol.2002.032011.</comment><pub-id pub-id-type="pmid">12562962</pub-id><pub-id pub-id-type="doi">10.1113/jphysiol.2002.032011</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vergnolle</surname><given-names>N</given-names></name><name><surname>Wallace</surname><given-names>JL</given-names></name><name><surname>Bunnett</surname><given-names>NW</given-names></name><name><surname>Hollenberg</surname><given-names>MD</given-names></name></person-group><article-title>Protease-activated receptors in inflammation, neuronal signaling and pain</article-title><source>Trends Pharmacol Sci</source><year>2001</year><volume>22</volume><fpage>146</fpage><lpage>152</lpage><pub-id pub-id-type="pmid">11239578</pub-id><pub-id pub-id-type="doi">10.1016/S0165-6147(00)01634-5</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vergnolle</surname><given-names>N</given-names></name><name><surname>Bunnett</surname><given-names>NW</given-names></name><name><surname>Sharkey</surname><given-names>KA</given-names></name><name><surname>Brussee</surname><given-names>V</given-names></name><name><surname>Compton</surname><given-names>SJ</given-names></name><name><surname>Grady</surname><given-names>EF</given-names></name><name><surname>Cirino</surname><given-names>G</given-names></name><name><surname>Gerard</surname><given-names>N</given-names></name><name><surname>Basbaum</surname><given-names>AI</given-names></name><name><surname>Andrade-Gordon</surname><given-names>P</given-names></name><name><surname>Hollenberg</surname><given-names>MD</given-names></name><name><surname>Wallace</surname><given-names>JL</given-names></name></person-group><article-title>Proteinase-activated receptor-2 and hyperalgesia: A novel pain pathway</article-title><source>Nat Med</source><year>2001</year><volume>7</volume><fpage>821</fpage><lpage>826</lpage><pub-id pub-id-type="pmid">11433347</pub-id><pub-id pub-id-type="doi">10.1038/89945</pub-id></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hollenberg</surname><given-names>D</given-names></name><name><surname>Compton</surname><given-names>S</given-names></name></person-group><article-title>International Union of Pharmacology. XXVIII. Proteinase-Activated Receptors</article-title><source>Pharmacol Reviews</source><year>2002</year><volume>54</volume><fpage>203</fpage><lpage>217</lpage><pub-id pub-id-type="doi">10.1124/pr.54.2.203</pub-id></citation></ref><ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vergnolle</surname><given-names>N</given-names></name></person-group><article-title>Review article: proteinase-activated receptors &#x02013; novel signals for gastrointestinal pathophysiology</article-title><source>Aliment Pharmacol Ther</source><year>2000</year><volume>14</volume><fpage>257</fpage><lpage>266</lpage><pub-id pub-id-type="pmid">10735917</pub-id><pub-id pub-id-type="doi">10.1046/j.1365-2036.2000.00690.x</pub-id></citation></ref><ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>D'Andrea</surname><given-names>MR</given-names></name><name><surname>Saban</surname><given-names>MR</given-names></name><name><surname>Nguyen</surname><given-names>NB</given-names></name><name><surname>Andrade-Gordon</surname><given-names>P</given-names></name><name><surname>Saban</surname><given-names>R</given-names></name></person-group><article-title>Expression of protease-activated receptor-1, -2, -3, and -4 in control and experimentally inflamed mouse bladder</article-title><source>Am J Pathol</source><year>2003</year><volume>162</volume><fpage>907</fpage><lpage>923</lpage><pub-id pub-id-type="pmid">12598324</pub-id></citation></ref><ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saban</surname><given-names>R</given-names></name><name><surname>D'Andrea</surname><given-names>MR</given-names></name><name><surname>Andrade-Gordon</surname><given-names>P</given-names></name><name><surname>Derian</surname><given-names>C</given-names></name><name><surname>Dozmorov</surname><given-names>I</given-names></name><name><surname>Ihnat</surname><given-names>MA</given-names></name><name><surname>Hurst</surname><given-names>RE</given-names></name><name><surname>Davis</surname><given-names>CA</given-names></name><name><surname>Simpson</surname><given-names>C</given-names></name><name><surname>Saban</surname><given-names>MR</given-names></name></person-group><article-title>Mandatory role of proteinase-activated receptor 1 in experimental bladder inflammation</article-title><source>BMC Physiol</source><year>2007</year><volume>7</volume><fpage>4</fpage><pub-id pub-id-type="pmid">17397548</pub-id><pub-id pub-id-type="doi">10.1186/1472-6793-7-4</pub-id></citation></ref><ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saban</surname><given-names>MR</given-names></name><name><surname>Nguyen</surname><given-names>NB</given-names></name><name><surname>Hammond</surname><given-names>TG</given-names></name><name><surname>Saban</surname><given-names>R</given-names></name></person-group><article-title>Gene expression profiling of mouse bladder inflammatory responses to LPS, substance P, and antigen-stimulation</article-title><source>Am J Pathol</source><year>2002</year><volume>160</volume><fpage>2095</fpage><lpage>2110</lpage><pub-id pub-id-type="pmid">12057914</pub-id></citation></ref><ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dattilio</surname><given-names>A</given-names></name><name><surname>Vizzard</surname><given-names>MA</given-names></name></person-group><article-title>Up-regulation of protease activated receptors in bladder after cyclophosphamide induced cystitis and colocalization with capsaicin receptor (VR1) in bladder nerve fibers</article-title><source>J Urol</source><year>2005</year><volume>173</volume><fpage>635</fpage><lpage>639</lpage><pub-id pub-id-type="pmid">15643279</pub-id><pub-id pub-id-type="doi">10.1097/01.ju.0000143191.55468.1d</pub-id></citation></ref><ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saban</surname><given-names>R</given-names></name><name><surname>D'Andrea</surname><given-names>MR</given-names></name><name><surname>Andrade-Gordon</surname><given-names>P</given-names></name><name><surname>Derian</surname><given-names>C</given-names></name><name><surname>Dozmorov</surname><given-names>I</given-names></name><name><surname>Ihnat</surname><given-names>MA</given-names></name><name><surname>Hurst</surname><given-names>RE</given-names></name><name><surname>Simpson</surname><given-names>C</given-names></name><name><surname>Saban</surname><given-names>MR</given-names></name></person-group><article-title>Regulatory network of inflammation Downstream Proteinase-Activated Receptors</article-title><source>BMC Physiol</source><year>2007</year><volume>7</volume><fpage>3</fpage><pub-id pub-id-type="pmid">17397547</pub-id><pub-id pub-id-type="doi">10.1186/1472-6793-7-3</pub-id></citation></ref><ref id="B26"><citation citation-type="other"><person-group person-group-type="author"><name><surname>Saban</surname><given-names>R</given-names></name><name><surname>D'Andrea</surname><given-names>MR</given-names></name><name><surname>Andrade-Gordon</surname><given-names>P</given-names></name><name><surname>Derian</surname><given-names>C</given-names></name><name><surname>Dozmorov</surname><given-names>I</given-names></name><name><surname>Ihnat</surname><given-names>MA</given-names></name><name><surname>Hurst</surname><given-names>RE</given-names></name><name><surname>Simpson</surname><given-names>C</given-names></name><name><surname>Saban</surname><given-names>MR</given-names></name></person-group><article-title>Regulatory Network of Inflammation Downstream Proteinase-Activated Receptors</article-title><source>BMC Physiol</source><year>2006</year><comment>(Manuscript # 1879346535122322 In Press): Submitted 16 Nov 2006.</comment></citation></ref><ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dozmorov</surname><given-names>I</given-names></name><name><surname>Saban</surname><given-names>MR</given-names></name><name><surname>Gerard</surname><given-names>NP</given-names></name><name><surname>Lu</surname><given-names>B</given-names></name><name><surname>Nguyen</surname><given-names>NB</given-names></name><name><surname>Centola</surname><given-names>M</given-names></name><name><surname>Saban</surname><given-names>R</given-names></name></person-group><article-title>Neurokinin 1 receptors and neprilysin modulation of mouse bladder gene regulation</article-title><source>Physiol Genomics</source><year>2003</year><volume>12</volume><fpage>239</fpage><lpage>250</lpage><pub-id pub-id-type="pmid">12499446</pub-id></citation></ref><ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saban</surname><given-names>MR</given-names></name><name><surname>Nguyen</surname><given-names>NB</given-names></name><name><surname>Hurst</surname><given-names>RE</given-names></name><name><surname>Saban</surname><given-names>R</given-names></name></person-group><article-title>Gene expression profiling of inflammatory bladder disorders</article-title><source>Expert Rev Mol Diagn</source><year>2003</year><volume>3</volume><fpage>217</fpage><lpage>235</lpage><pub-id pub-id-type="pmid">12647997</pub-id><pub-id pub-id-type="doi">10.1586/14737159.3.2.217</pub-id></citation></ref><ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saban</surname><given-names>MR</given-names></name><name><surname>Saban</surname><given-names>R</given-names></name><name><surname>Hammond</surname><given-names>TG</given-names></name><name><surname>Haak-Frendscho</surname><given-names>M</given-names></name><name><surname>Steinberg</surname><given-names>H</given-names></name><name><surname>Tengowski</surname><given-names>MW</given-names></name><name><surname>Bjorling</surname><given-names>DE</given-names></name></person-group><article-title>LPS-sensory peptide communication in experimental cystitis</article-title><source>Am J Physiol Renal Physiol</source><year>2002</year><volume>282</volume><fpage>F202</fpage><lpage>210</lpage><pub-id pub-id-type="pmid">11788433</pub-id></citation></ref><ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Macfarlane</surname><given-names>SR</given-names></name><name><surname>Seatter</surname><given-names>MJ</given-names></name><name><surname>Kanke</surname><given-names>T</given-names></name><name><surname>Hunter</surname><given-names>GD</given-names></name><name><surname>Plevin</surname><given-names>R</given-names></name></person-group><article-title>Proteinase-activated receptors</article-title><source>Pharmacological reviews</source><year>2001</year><volume>53</volume><fpage>245</fpage><lpage>282</lpage><pub-id pub-id-type="pmid">11356985</pub-id></citation></ref><ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Faruqi</surname><given-names>TR</given-names></name><name><surname>Weiss</surname><given-names>EJ</given-names></name><name><surname>Shapiro</surname><given-names>MJ</given-names></name><name><surname>Huang</surname><given-names>W</given-names></name><name><surname>Coughlin</surname><given-names>SR</given-names></name></person-group><article-title>Structure-function analysis of protease-activated receptor 4 tethered ligand peptides. Determinants of specificity and utility in assaysof receptor function</article-title><source>J Biol Chem</source><year>2000</year><volume>275</volume><fpage>19728</fpage><lpage>19734</lpage><pub-id pub-id-type="pmid">10779527</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M909960199</pub-id></citation></ref><ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saban</surname><given-names>MR</given-names></name><name><surname>Hellmich</surname><given-names>HL</given-names></name><name><surname>Turner</surname><given-names>M</given-names></name><name><surname>Nguyen</surname><given-names>NB</given-names></name><name><surname>Vadigepalli</surname><given-names>R</given-names></name><name><surname>Dyer</surname><given-names>DW</given-names></name><name><surname>Hurst</surname><given-names>RE</given-names></name><name><surname>Centola</surname><given-names>M</given-names></name><name><surname>Saban</surname><given-names>R</given-names></name></person-group><article-title>The inflammatory and normal transcriptome of mouse bladder detrusor and mucosa</article-title><source>BMC Physiol</source><year>2006</year><volume>6</volume><fpage>1</fpage><pub-id pub-id-type="pmid">16420690</pub-id><pub-id pub-id-type="doi">10.1186/1472-6793-6-1</pub-id></citation></ref><ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brazma</surname><given-names>A</given-names></name><name><surname>Hingamp</surname><given-names>P</given-names></name><name><surname>Quackenbush</surname><given-names>J</given-names></name><name><surname>Sherlock</surname><given-names>G</given-names></name><name><surname>Spellman</surname><given-names>P</given-names></name><name><surname>Stoeckert</surname><given-names>C</given-names></name><name><surname>Aach</surname><given-names>J</given-names></name><name><surname>Ansorge</surname><given-names>W</given-names></name><name><surname>Ball</surname><given-names>CA</given-names></name><name><surname>Causton</surname><given-names>HC</given-names></name><name><surname>Gaasterland</surname><given-names>T</given-names></name><name><surname>Glenisson</surname><given-names>P</given-names></name><name><surname>Holstege</surname><given-names>FC</given-names></name><name><surname>Kim</surname><given-names>IF</given-names></name><name><surname>Markowitz</surname><given-names>V</given-names></name><name><surname>Matese</surname><given-names>JC</given-names></name><name><surname>Parkinson</surname><given-names>H</given-names></name><name><surname>Robinson</surname><given-names>A</given-names></name><name><surname>Sarkans</surname><given-names>U</given-names></name><name><surname>Schulze-Kremer</surname><given-names>S</given-names></name><name><surname>Stewart</surname><given-names>J</given-names></name><name><surname>Taylor</surname><given-names>R</given-names></name><name><surname>Vilo</surname><given-names>J</given-names></name><name><surname>Vingron</surname><given-names>M</given-names></name></person-group><article-title>Minimum information about a microarray experiment (MIAME)-toward standards for microarray data</article-title><source>Nat Genet</source><year>2001</year><volume>29</volume><fpage>365</fpage><lpage>371</lpage><pub-id pub-id-type="pmid">11726920</pub-id><pub-id pub-id-type="doi">10.1038/ng1201-365</pub-id></citation></ref><ref id="B34"><citation citation-type="other"><article-title>Panomics</article-title><ext-link ext-link-type="uri" xlink:href="http://www.panomics.com/"/></citation></ref><ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dozmorov</surname><given-names>I</given-names></name><name><surname>Saban</surname><given-names>MR</given-names></name><name><surname>Knowlton</surname><given-names>N</given-names></name><name><surname>Centola</surname><given-names>M</given-names></name><name><surname>Saban</surname><given-names>R</given-names></name></person-group><article-title>Connective molecular pathways of experimental bladder inflammation</article-title><source>Physiol Genomics</source><year>2003</year><volume>15</volume><fpage>209</fpage><lpage>222</lpage><pub-id pub-id-type="pmid">12966137</pub-id></citation></ref><ref id="B36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saban</surname><given-names>R</given-names></name><name><surname>Simpson</surname><given-names>C</given-names></name><name><surname>Vadigepalli</surname><given-names>R</given-names></name><name><surname>Memet</surname><given-names>S</given-names></name><name><surname>Dozmorov</surname><given-names>I</given-names></name><name><surname>Saban</surname><given-names>MR</given-names></name></person-group><article-title>Bladder inflammatory transcriptome in response to tachykinins:Neurokinin 1 receptor-dependent genes and transcription regulatory elements</article-title><source>BMC Urology</source><year>2007</year><volume>7</volume><fpage>7</fpage><pub-id pub-id-type="pmid">17519035</pub-id><pub-id pub-id-type="doi">10.1186/1471-2490-7-7</pub-id></citation></ref><ref id="B37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dozmorov</surname><given-names>I</given-names></name><name><surname>Centola</surname><given-names>M</given-names></name></person-group><article-title>An associative analysis of gene expression array data</article-title><source>Bioinformatics</source><year>2003</year><volume>19</volume><fpage>204</fpage><lpage>211</lpage><pub-id pub-id-type="pmid">12538240</pub-id><pub-id pub-id-type="doi">10.1093/bioinformatics/19.2.204</pub-id></citation></ref><ref id="B38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fisher</surname><given-names>DE</given-names></name><name><surname>Carr</surname><given-names>CS</given-names></name><name><surname>Parent</surname><given-names>LA</given-names></name><name><surname>Sharp</surname><given-names>PA</given-names></name></person-group><article-title>TFEB has DNA-binding and oligomerization properties of a unique helix-loop-helix/leucine-zipper family</article-title><source>Genes Dev</source><year>1991</year><volume>5</volume><fpage>2342</fpage><lpage>2352</lpage><pub-id pub-id-type="pmid">1748288</pub-id><pub-id pub-id-type="doi">10.1101/gad.5.12a.2342</pub-id></citation></ref><ref id="B39"><citation citation-type="other"><article-title>Image J software</article-title><ext-link ext-link-type="uri" xlink:href="http://rsb.info.nih.gov/ij/"/></citation></ref><ref id="B40"><citation citation-type="other"><article-title>Genpathway</article-title><ext-link ext-link-type="uri" xlink:href="http://www.genpathway.com/"/></citation></ref><ref id="B41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Labhart</surname><given-names>P</given-names></name><name><surname>Karmakar</surname><given-names>S</given-names></name><name><surname>Salicru</surname><given-names>EM</given-names></name><name><surname>Egan</surname><given-names>BS</given-names></name><name><surname>Alexiadis</surname><given-names>V</given-names></name><name><surname>O'Malley</surname><given-names>BW</given-names></name><name><surname>Smith</surname><given-names>CL</given-names></name></person-group><article-title>Identification of target genes in breast cancer cells directly regulated by the SRC-3/AIB1 coactivator</article-title><source>Proc Natl Acad Sci USA</source><year>2005</year><volume>102</volume><fpage>1339</fpage><lpage>1344</lpage><pub-id pub-id-type="pmid">15677324</pub-id><pub-id pub-id-type="doi">10.1073/pnas.0409578102</pub-id></citation></ref><ref id="B42"><citation citation-type="other"><article-title>Primer 3</article-title><ext-link ext-link-type="uri" xlink:href="http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi"/></citation></ref><ref id="B43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dozmorov</surname><given-names>MG</given-names></name><name><surname>Kyker</surname><given-names>KD</given-names></name><name><surname>Saban</surname><given-names>R</given-names></name><name><surname>Knowlton</surname><given-names>N</given-names></name><name><surname>Dozmorov</surname><given-names>I</given-names></name><name><surname>Centola</surname><given-names>MB</given-names></name><name><surname>Hurst</surname><given-names>RE</given-names></name></person-group><article-title>Analysis of the interaction of extracellular matrix and phenotype of bladder cancer cells</article-title><source>BMC Cancer</source><year>2006</year><volume>6</volume><fpage>12</fpage><pub-id pub-id-type="pmid">16412233</pub-id><pub-id pub-id-type="doi">10.1186/1471-2407-6-12</pub-id></citation></ref><ref id="B44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bjorling</surname><given-names>DE</given-names></name><name><surname>Jerde</surname><given-names>TJ</given-names></name><name><surname>Zine</surname><given-names>MJ</given-names></name><name><surname>Busser</surname><given-names>BW</given-names></name><name><surname>Saban</surname><given-names>MR</given-names></name><name><surname>Saban</surname><given-names>R</given-names></name></person-group><article-title>Mast cells mediate the severity of experimental cystitis in mice</article-title><source>J Urol</source><year>1999</year><volume>162</volume><fpage>231</fpage><lpage>236</lpage><pub-id pub-id-type="pmid">10379792</pub-id><pub-id pub-id-type="doi">10.1097/00005392-199907000-00073</pub-id></citation></ref><ref id="B45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Esumi</surname><given-names>N</given-names></name><name><surname>Oshima</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Campochiaro</surname><given-names>PA</given-names></name><name><surname>Zack</surname><given-names>DJ</given-names></name></person-group><article-title>Analysis of the VMD2 promoter and implication of E-box binding factors in its regulation</article-title><source>J Biol Chem</source><year>2004</year><volume>279</volume><fpage>19064</fpage><lpage>19073</lpage><pub-id pub-id-type="pmid">14982938</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M309881200</pub-id></citation></ref><ref id="B46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Takemoto</surname><given-names>CM</given-names></name><name><surname>Yoon</surname><given-names>YJ</given-names></name><name><surname>Fisher</surname><given-names>DE</given-names></name></person-group><article-title>The identification and functional characterization of a novel mast cell isoform of the microphthalmia-associated transcription factor</article-title><source>J Biol Chem</source><year>2002</year><volume>277</volume><fpage>30244</fpage><lpage>30252</lpage><pub-id pub-id-type="pmid">12039954</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M201441200</pub-id></citation></ref><ref id="B47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Semov</surname><given-names>A</given-names></name><name><surname>Marcotte</surname><given-names>R</given-names></name><name><surname>Semova</surname><given-names>N</given-names></name><name><surname>Ye</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>E</given-names></name></person-group><article-title>Microarray analysis of E-box binding-related gene expression in young and replicatively senescent human fibroblasts</article-title><source>Anal Biochem</source><year>2002</year><volume>302</volume><fpage>38</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">11846374</pub-id><pub-id pub-id-type="doi">10.1006/abio.2001.5515</pub-id></citation></ref><ref id="B48"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hershey</surname><given-names>CL</given-names></name><name><surname>Fisher</surname><given-names>DE</given-names></name></person-group><article-title>Mitf and Tfe3: members of a b-HLH-ZIP transcription factor family essential for osteoclast development and function</article-title><source>Bone</source><year>2004</year><volume>34</volume><fpage>689</fpage><lpage>696</lpage><pub-id pub-id-type="pmid">15050900</pub-id><pub-id pub-id-type="doi">10.1016/j.bone.2003.08.014</pub-id></citation></ref><ref id="B49"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shahlaee</surname><given-names>AH</given-names></name><name><surname>Brandal</surname><given-names>S</given-names></name><name><surname>Lee</surname><given-names>YN</given-names></name><name><surname>Jie</surname><given-names>C</given-names></name><name><surname>Takemoto</surname><given-names>CM</given-names></name></person-group><article-title>Distinct and shared transcriptomes are regulated by microphthalmia-associated transcription factor isoforms in mast cells</article-title><source>J Immunol</source><year>2007</year><volume>178</volume><fpage>378</fpage><lpage>388</lpage><pub-id pub-id-type="pmid">17182576</pub-id></citation></ref><ref id="B50"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zanocco-Marani</surname><given-names>T</given-names></name><name><surname>Vignudelli</surname><given-names>T</given-names></name><name><surname>Gemelli</surname><given-names>C</given-names></name><name><surname>Pirondi</surname><given-names>S</given-names></name><name><surname>Testa</surname><given-names>A</given-names></name><name><surname>Montanari</surname><given-names>M</given-names></name><name><surname>Parenti</surname><given-names>S</given-names></name><name><surname>Tenedini</surname><given-names>E</given-names></name><name><surname>Grande</surname><given-names>A</given-names></name><name><surname>Ferrari</surname><given-names>S</given-names></name></person-group><article-title>Tfe3 expression is closely associated to macrophage terminal differentiation of human hematopoietic myeloid precursors</article-title><source>Exp Cell Res</source><year>2006</year><volume>312</volume><fpage>4079</fpage><lpage>4089</lpage><pub-id pub-id-type="pmid">17046750</pub-id><pub-id pub-id-type="doi">10.1016/j.yexcr.2006.09.015</pub-id></citation></ref><ref id="B51"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>AJ</given-names></name><name><surname>Levy</surname><given-names>C</given-names></name><name><surname>Davis</surname><given-names>IJ</given-names></name><name><surname>Razin</surname><given-names>E</given-names></name><name><surname>Fisher</surname><given-names>DE</given-names></name></person-group><article-title>Sumoylation of MITF and its related family members TFE3 and TFEB</article-title><source>J Biol Chem</source><year>2005</year><volume>280</volume><fpage>146</fpage><lpage>155</lpage><pub-id pub-id-type="pmid">15507434</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M508430200</pub-id></citation></ref><ref id="B52"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rehli</surname><given-names>M</given-names></name><name><surname>Den Elzen</surname><given-names>N</given-names></name><name><surname>Cassady</surname><given-names>AI</given-names></name><name><surname>Ostrowski</surname><given-names>MC</given-names></name><name><surname>Hume</surname><given-names>DA</given-names></name></person-group><article-title>Cloning and characterization of the murine genes for bHLH-ZIP transcription factors TFEC and TFEB reveal a common gene organization for all MiT subfamily members</article-title><source>Genomics</source><year>1999</year><volume>56</volume><fpage>111</fpage><lpage>120</lpage><pub-id pub-id-type="pmid">10036191</pub-id><pub-id pub-id-type="doi">10.1006/geno.1998.5588</pub-id></citation></ref><ref id="B53"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Russo</surname><given-names>P</given-names></name></person-group><article-title>Translocation carcinomas of the kidney after chemotherapy in childhood Argani P, Lae M, Ballard ET, Amin M, Manivel C, Hutchinson B, Reuter VE, Ladanyi M, Department of Pathology, The Johns Hopkins Hospital, Baltimore, MD</article-title><source>Urol Oncol</source><year>2006</year><volume>24</volume><fpage>558</fpage><lpage>559</lpage></citation></ref><ref id="B54"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huan</surname><given-names>C</given-names></name><name><surname>Sashital</surname><given-names>D</given-names></name><name><surname>Hailemariam</surname><given-names>T</given-names></name><name><surname>Kelly</surname><given-names>ML</given-names></name><name><surname>Roman</surname><given-names>CA</given-names></name></person-group><article-title>Renal carcinoma-associated transcription factors TFE3 and TFEB are leukemia inhibitory factor-responsive transcription activators of E-cadherin</article-title><source>J Biol Chem</source><year>2005</year><volume>280</volume><fpage>30225</fpage><lpage>30235</lpage><pub-id pub-id-type="pmid">15994295</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M502380200</pub-id></citation></ref><ref id="B55"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Babina</surname><given-names>M</given-names></name><name><surname>Schulke</surname><given-names>Y</given-names></name><name><surname>Kirchhof</surname><given-names>L</given-names></name><name><surname>Guhl</surname><given-names>S</given-names></name><name><surname>Franke</surname><given-names>R</given-names></name><name><surname>Bohm</surname><given-names>S</given-names></name><name><surname>Zuberbier</surname><given-names>T</given-names></name><name><surname>Henz</surname><given-names>BM</given-names></name><name><surname>Gombart</surname><given-names>AF</given-names></name></person-group><article-title>The transcription factor profile of human mast cells in comparison with monocytes and granulocytes</article-title><source>Cell Mol Life Sci</source><year>2005</year><volume>62</volume><fpage>214</fpage><lpage>226</lpage><pub-id pub-id-type="pmid">15666093</pub-id><pub-id pub-id-type="doi">10.1007/s00018-004-4480-6</pub-id></citation></ref><ref id="B56"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kitamura</surname><given-names>Y</given-names></name><name><surname>Oboki</surname><given-names>K</given-names></name><name><surname>Ito</surname><given-names>A</given-names></name></person-group><article-title>Molecular mechanisms of mast cell development</article-title><source>Immunology and allergy clinics of North America</source><year>2006</year><volume>26</volume><fpage>387</fpage><lpage>405</lpage><comment>v.</comment><pub-id pub-id-type="pmid">16931285</pub-id><pub-id pub-id-type="doi">10.1016/j.iac.2006.05.004</pub-id></citation></ref><ref id="B57"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fisher</surname><given-names>DE</given-names></name></person-group><article-title>Microphthalmia: a signal responsive transcriptional regulator in development</article-title><source>Pigment cell research/sponsored by the European Society for Pigment Cell Research and the International Pigment Cell Society</source><year>2000</year><volume>13</volume><fpage>145</fpage><lpage>149</lpage><pub-id pub-id-type="pmid">11041373</pub-id></citation></ref><ref id="B58"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McGill</surname><given-names>GG</given-names></name><name><surname>Horstmann</surname><given-names>M</given-names></name><name><surname>Widlund</surname><given-names>HR</given-names></name><name><surname>Du</surname><given-names>J</given-names></name><name><surname>Motyckova</surname><given-names>G</given-names></name><name><surname>Nishimura</surname><given-names>EK</given-names></name><name><surname>Lin</surname><given-names>YL</given-names></name><name><surname>Ramaswamy</surname><given-names>S</given-names></name><name><surname>Avery</surname><given-names>W</given-names></name><name><surname>Ding</surname><given-names>HF</given-names></name><name><surname>Jordan</surname><given-names>SA</given-names></name><name><surname>Jackson</surname><given-names>IJ</given-names></name><name><surname>Korsmeyer</surname><given-names>SJ</given-names></name><name><surname>Golub</surname><given-names>TR</given-names></name><name><surname>Fisher</surname><given-names>DE</given-names></name></person-group><article-title>Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability</article-title><source>Cell</source><year>2002</year><volume>109</volume><fpage>707</fpage><lpage>718</lpage><pub-id pub-id-type="pmid">12086670</pub-id><pub-id pub-id-type="doi">10.1016/S0092-8674(02)00762-6</pub-id></citation></ref><ref id="B59"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Widlund</surname><given-names>HR</given-names></name><name><surname>Horstmann</surname><given-names>MA</given-names></name><name><surname>Price</surname><given-names>ER</given-names></name><name><surname>Cui</surname><given-names>J</given-names></name><name><surname>Lessnick</surname><given-names>SL</given-names></name><name><surname>Wu</surname><given-names>M</given-names></name><name><surname>He</surname><given-names>X</given-names></name><name><surname>Fisher</surname><given-names>DE</given-names></name></person-group><article-title>Beta-catenin-induced melanoma growth requires the downstream target Microphthalmia-associated transcription factor</article-title><source>J Cell Biol</source><year>2002</year><volume>158</volume><fpage>1079</fpage><lpage>1087</lpage><pub-id pub-id-type="pmid">12235125</pub-id><pub-id pub-id-type="doi">10.1083/jcb.200202049</pub-id></citation></ref><ref id="B60"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Steingrimsson</surname><given-names>E</given-names></name><name><surname>Copeland</surname><given-names>NG</given-names></name><name><surname>Jenkins</surname><given-names>NA</given-names></name></person-group><article-title>Melanocytes and the microphthalmia transcription factor network</article-title><source>Annual review of genetics</source><year>2004</year><volume>38</volume><fpage>365</fpage><lpage>411</lpage><pub-id pub-id-type="pmid">15568981</pub-id><pub-id pub-id-type="doi">10.1146/annurev.genet.38.072902.092717</pub-id></citation></ref><ref id="B61"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Camerer</surname><given-names>E</given-names></name><name><surname>Huang</surname><given-names>W</given-names></name><name><surname>Coughlin</surname><given-names>SR</given-names></name></person-group><article-title>Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa</article-title><source>Proc Natl Acad Sci USA</source><year>2000</year><volume>97</volume><fpage>5255</fpage><lpage>5260</lpage><pub-id pub-id-type="pmid">10805786</pub-id><pub-id pub-id-type="doi">10.1073/pnas.97.10.5255</pub-id></citation></ref><ref id="B62"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McLaughlin</surname><given-names>JN</given-names></name><name><surname>Mazzoni</surname><given-names>MR</given-names></name><name><surname>Cleator</surname><given-names>JH</given-names></name><name><surname>Earls</surname><given-names>L</given-names></name><name><surname>Perdigoto</surname><given-names>AL</given-names></name><name><surname>Brooks</surname><given-names>JD</given-names></name><name><surname>Muldowney</surname><given-names>JA</given-names><suffix>3rd</suffix></name><name><surname>Vaughan</surname><given-names>DE</given-names></name><name><surname>Hamm</surname><given-names>HE</given-names></name></person-group><article-title>Thrombin modulates the expression of a set of genes including thrombospondin-1 in human microvascular endothelial cells</article-title><source>J Biol Chem</source><year>2005</year><volume>280</volume><fpage>22172</fpage><lpage>22180</lpage><pub-id pub-id-type="pmid">15817447</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M500721200</pub-id></citation></ref><ref id="B63"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Abraham</surname><given-names>D</given-names></name><name><surname>Oster</surname><given-names>H</given-names></name><name><surname>Huber</surname><given-names>M</given-names></name><name><surname>Leitges</surname><given-names>M</given-names></name></person-group><article-title>The expression pattern of three mast cell specific proteases during mouse development</article-title><source>Mol Immunol</source><year>2007</year><volume>44</volume><fpage>732</fpage><lpage>740</lpage><pub-id pub-id-type="pmid">16777228</pub-id><pub-id pub-id-type="doi">10.1016/j.molimm.2006.04.019</pub-id></citation></ref><ref id="B64"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>DK</given-names></name><name><surname>Lee</surname><given-names>YM</given-names></name></person-group><article-title>Requirement of c-jun transcription factor on the mouse mast cell protease-6 expression in the mast cells</article-title><source>Arch Biochem Biophys</source><year>2004</year><volume>431</volume><fpage>71</fpage><lpage>78</lpage><pub-id pub-id-type="pmid">15464728</pub-id><pub-id pub-id-type="doi">10.1016/j.abb.2004.07.027</pub-id></citation></ref><ref id="B65"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>GW</given-names></name><name><surname>Yasuda</surname><given-names>S</given-names></name><name><surname>Morokawa</surname><given-names>N</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Stevens</surname><given-names>RL</given-names></name></person-group><article-title>Mouse chromosome 17A3.3 contains 13 genes that encode functional tryptic-like serine proteases with distinct tissue and cell expression patterns</article-title><source>J Biol Chem</source><year>2004</year><volume>279</volume><fpage>2438</fpage><lpage>2452</lpage><pub-id pub-id-type="pmid">14583634</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M308209200</pub-id></citation></ref><ref id="B66"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Funaba</surname><given-names>M</given-names></name><name><surname>Ikeda</surname><given-names>T</given-names></name><name><surname>Murakami</surname><given-names>M</given-names></name><name><surname>Ogawa</surname><given-names>K</given-names></name><name><surname>Nishino</surname><given-names>Y</given-names></name><name><surname>Tsuchida</surname><given-names>K</given-names></name><name><surname>Sugino</surname><given-names>H</given-names></name><name><surname>Abe</surname><given-names>M</given-names></name></person-group><article-title>Transcriptional regulation of mouse mast cell protease-7 by TGF-beta</article-title><source>Biochimica et biophysica acta</source><year>2006</year><volume>1759</volume><fpage>166</fpage><lpage>170</lpage><pub-id pub-id-type="pmid">16730810</pub-id></citation></ref><ref id="B67"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Oikonomopoulou</surname><given-names>K</given-names></name><name><surname>Hansen</surname><given-names>KK</given-names></name><name><surname>Saifeddine</surname><given-names>M</given-names></name><name><surname>Tea</surname><given-names>I</given-names></name><name><surname>Blaber</surname><given-names>M</given-names></name><name><surname>Blaber</surname><given-names>SI</given-names></name><name><surname>Scarisbrick</surname><given-names>I</given-names></name><name><surname>Andrade-Gordon</surname><given-names>P</given-names></name><name><surname>Cottrell</surname><given-names>GS</given-names></name><name><surname>Bunnett</surname><given-names>NW</given-names></name><name><surname>Diamandis</surname><given-names>EP</given-names></name><name><surname>Hollenberg</surname><given-names>MD</given-names></name></person-group><article-title>Proteinase-activated receptors, targets for kallikrein signaling</article-title><source>J Biol Chem</source><year>2006</year><volume>281</volume><fpage>32095</fpage><lpage>32112</lpage><pub-id pub-id-type="pmid">16885167</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M513138200</pub-id></citation></ref><ref id="B68"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>de Groat</surname><given-names>WC</given-names></name></person-group><article-title>Integrative control of the lower urinary tract: preclinical perspective</article-title><source>Br J Pharmacol</source><year>2006</year><volume>147</volume><fpage>S25</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">16465182</pub-id><pub-id pub-id-type="doi">10.1038/sj.bjp.0706604</pub-id></citation></ref><ref id="B69"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sundram</surname><given-names>UN</given-names></name><name><surname>Natkunam</surname><given-names>Y</given-names></name></person-group><article-title>Mast cell tryptase and microphthalmia transcription factor effectively discriminate cutaneous mast cell disease from myeloid leukemia cutis</article-title><source>Journal of cutaneous pathology</source><year>2007</year><volume>34</volume><fpage>289</fpage><lpage>295</lpage><pub-id pub-id-type="pmid">17381798</pub-id><pub-id pub-id-type="doi">10.1111/j.1600-0560.2006.00602.x</pub-id></citation></ref><ref id="B70"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Funaba</surname><given-names>M</given-names></name><name><surname>Ikeda</surname><given-names>T</given-names></name><name><surname>Murakami</surname><given-names>M</given-names></name><name><surname>Ogawa</surname><given-names>K</given-names></name><name><surname>Tsuchida</surname><given-names>K</given-names></name><name><surname>Sugino</surname><given-names>H</given-names></name><name><surname>Abe</surname><given-names>M</given-names></name></person-group><article-title>Transcriptional activation of mouse mast cell Protease-7 by activin and transforming growth factor-beta is inhibited by microphthalmia-associated transcription factor</article-title><source>J Biol Chem</source><year>2003</year><volume>278</volume><fpage>52032</fpage><lpage>52041</lpage><pub-id pub-id-type="pmid">14527958</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M306991200</pub-id></citation></ref><ref id="B71"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Funaba</surname><given-names>M</given-names></name><name><surname>Ikeda</surname><given-names>T</given-names></name><name><surname>Murakami</surname><given-names>M</given-names></name><name><surname>Ogawa</surname><given-names>K</given-names></name><name><surname>Abe</surname><given-names>M</given-names></name></person-group><article-title>Up-regulation of mouse mast cell protease-6 gene by transforming growth factor-beta and activin in mast cell progenitors</article-title><source>Cellular signalling</source><year>2005</year><volume>17</volume><fpage>121</fpage><lpage>128</lpage><pub-id pub-id-type="pmid">15451032</pub-id><pub-id pub-id-type="doi">10.1016/j.cellsig.2004.06.005</pub-id></citation></ref><ref id="B72"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Metcalfe</surname><given-names>DD</given-names></name><name><surname>Baram</surname><given-names>D</given-names></name><name><surname>Mekori</surname><given-names>YA</given-names></name></person-group><article-title>Mast cells</article-title><source>Physiol Rev</source><year>1997</year><volume>77</volume><fpage>1033</fpage><lpage>1079</lpage><pub-id pub-id-type="pmid">9354811</pub-id></citation></ref><ref id="B73"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schwartz</surname><given-names>LB</given-names></name><name><surname>Irani</surname><given-names>AM</given-names></name><name><surname>Roller</surname><given-names>K</given-names></name><name><surname>Castells</surname><given-names>MC</given-names></name><name><surname>Schechter</surname><given-names>NM</given-names></name></person-group><article-title>Quantitation of histamine, tryptase, and chymase in dispersed human T and TC mast cells</article-title><source>J Immunol</source><year>1987</year><volume>138</volume><fpage>2611</fpage><lpage>2615</lpage><pub-id pub-id-type="pmid">3549903</pub-id></citation></ref><ref id="B74"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Caughey</surname><given-names>GH</given-names></name></person-group><article-title>Of mites and men: trypsin-like proteases in the lungs</article-title><source>Am J Respir Cell Mol Biol</source><year>1997</year><volume>16</volume><fpage>621</fpage><lpage>628</lpage><pub-id pub-id-type="pmid">9191463</pub-id></citation></ref><ref id="B75"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Theoharides</surname><given-names>TC</given-names></name></person-group><article-title>The mast cell: a neuroimmunoendocrine master player</article-title><source>Int J Tissue React</source><year>1996</year><volume>18</volume><fpage>1</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">8880375</pub-id></citation></ref><ref id="B76"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yamada</surname><given-names>T</given-names></name><name><surname>Murayama</surname><given-names>T</given-names></name><name><surname>Mita</surname><given-names>H</given-names></name><name><surname>Akiyama</surname><given-names>K</given-names></name></person-group><article-title>Subtypes of bladder mast cells in interstitial cystitis. I</article-title><source>Inter J Urol</source><year>2000</year><volume>7</volume><fpage>292</fpage><lpage>297</lpage><pub-id pub-id-type="doi">10.1046/j.1442-2042.2000.00197.x</pub-id></citation></ref><ref id="B77"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tomaszewski</surname><given-names>J</given-names></name><name><surname>Landis</surname><given-names>J</given-names></name><name><surname>Russack</surname><given-names>V</given-names></name><name><surname>Williams</surname><given-names>T</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Hardy</surname><given-names>C</given-names></name><name><surname>Brensinger</surname><given-names>C</given-names></name><name><surname>Matthews</surname><given-names>Y</given-names></name><name><surname>Abele</surname><given-names>S</given-names></name><name><surname>Kusek</surname><given-names>J</given-names></name><name><surname>Nyberg</surname><given-names>L</given-names></name></person-group><article-title>The Interstitial Cystitis Database Study Group. Biopsy features are associated with primary symptoms in interstitial cystitis: results from the interstitial cystitis database study</article-title><source>Urology</source><year>2001</year><volume>57</volume><fpage>67</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">11378053</pub-id><pub-id pub-id-type="doi">10.1016/S0090-4295(01)01166-9</pub-id></citation></ref><ref id="B78"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moormann</surname><given-names>C</given-names></name><name><surname>Artuc</surname><given-names>M</given-names></name><name><surname>Pohl</surname><given-names>E</given-names></name><name><surname>Varga</surname><given-names>G</given-names></name><name><surname>Buddenkotte</surname><given-names>J</given-names></name><name><surname>Vergnolle</surname><given-names>N</given-names></name><name><surname>Brehler</surname><given-names>R</given-names></name><name><surname>Henz</surname><given-names>BM</given-names></name><name><surname>Schneider</surname><given-names>SW</given-names></name><name><surname>Luger</surname><given-names>TA</given-names></name><name><surname>Steinhoff</surname><given-names>M</given-names></name></person-group><article-title>Functional characterization and expression analysis of the proteinase-activated receptor-2 in human cutaneous mast cells</article-title><source>J Invest Dermatol</source><year>2006</year><volume>126</volume><fpage>746</fpage><lpage>755</lpage><pub-id pub-id-type="pmid">16470180</pub-id><pub-id pub-id-type="doi">10.1038/sj.jid.5700169</pub-id></citation></ref><ref id="B79"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vliagoftis</surname><given-names>H</given-names></name></person-group><article-title>Thrombin induces mast cell adhesion to fibronectin: evidence for involvement of protease-activated receptor-1</article-title><source>J Immunol</source><year>2002</year><volume>169</volume><fpage>4551</fpage><lpage>4558</lpage><pub-id pub-id-type="pmid">12370392</pub-id></citation></ref><ref id="B80"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nishikawa</surname><given-names>H</given-names></name><name><surname>Kawabata</surname><given-names>A</given-names></name><name><surname>Kuroda</surname><given-names>R</given-names></name><name><surname>Nishida</surname><given-names>M</given-names></name><name><surname>Kawai</surname><given-names>K</given-names></name></person-group><article-title>Characterization of protease-activated receptors in rat peritoneal mast cells</article-title><source>Japanese journal of pharmacology</source><year>2000</year><volume>82</volume><fpage>74</fpage><lpage>77</lpage><pub-id pub-id-type="pmid">10874593</pub-id><pub-id pub-id-type="doi">10.1254/jjp.82.74</pub-id></citation></ref><ref id="B81"><citation citation-type="other"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Yang</surname><given-names>X</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Lin</surname><given-names>Q</given-names></name><name><surname>Zheng</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Yang</surname><given-names>P</given-names></name><name><surname>He</surname><given-names>S</given-names></name></person-group><article-title>Modulation of mast cell proteinase-activated receptor expression and IL-4 release by IL-12</article-title><source>Immunol Cell Biol</source><year>2007</year><comment>Epub ahead of print</comment></citation></ref><ref id="B82"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>W</given-names></name><name><surname>Mitchell</surname><given-names>P</given-names></name><name><surname>Tjian</surname><given-names>R</given-names></name></person-group><article-title>Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements</article-title><source>Cell</source><year>1987</year><volume>49</volume><fpage>741</fpage><lpage>752</lpage><pub-id pub-id-type="pmid">3034433</pub-id><pub-id pub-id-type="doi">10.1016/0092-8674(87)90612-X</pub-id></citation></ref><ref id="B83"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>T</given-names></name><name><surname>Admon</surname><given-names>A</given-names></name><name><surname>Luscher</surname><given-names>B</given-names></name><name><surname>Tjian</surname><given-names>R</given-names></name></person-group><article-title>Cloning and expression of AP-2, a cell-type-specific transcription factor that activates inducible enhancer elements</article-title><source>Genes Dev</source><year>1988</year><volume>2</volume><fpage>1557</fpage><lpage>1569</lpage><pub-id pub-id-type="pmid">3063603</pub-id><pub-id pub-id-type="doi">10.1101/gad.2.12a.1557</pub-id></citation></ref><ref id="B84"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xiang</surname><given-names>M</given-names></name><name><surname>Zhou</surname><given-names>L</given-names></name><name><surname>Macke</surname><given-names>JP</given-names></name><name><surname>Yoshioka</surname><given-names>T</given-names></name><name><surname>Hendry</surname><given-names>SH</given-names></name><name><surname>Eddy</surname><given-names>RL</given-names></name><name><surname>Shows</surname><given-names>TB</given-names></name><name><surname>Nathans</surname><given-names>J</given-names></name></person-group><article-title>The Brn-3 family of POU-domain factors: primary structure, binding specificity, and expression in subsets of retinal ganglion cells and somatosensory neurons</article-title><source>J Neurosci</source><year>1995</year><volume>15</volume><fpage>4762</fpage><lpage>4785</lpage><pub-id pub-id-type="pmid">7623109</pub-id></citation></ref><ref id="B85"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Decker</surname><given-names>T</given-names></name><name><surname>Lew</surname><given-names>DJ</given-names></name><name><surname>Mirkovitch</surname><given-names>J</given-names></name><name><surname>Darnell</surname><given-names>JE</given-names><suffix>Jr</suffix></name></person-group><article-title>Cytoplasmic activation of GAF, an IFN-gamma-regulated DNA-binding factor</article-title><source>Embo J</source><year>1991</year><volume>10</volume><fpage>927</fpage><lpage>932</lpage><pub-id pub-id-type="pmid">1901265</pub-id></citation></ref><ref id="B86"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sadat</surname><given-names>MA</given-names></name><name><surname>Kumatori</surname><given-names>A</given-names></name><name><surname>Suzuki</surname><given-names>S</given-names></name><name><surname>Yamaguchi</surname><given-names>Y</given-names></name><name><surname>Tsuji</surname><given-names>Y</given-names></name><name><surname>Nakamura</surname><given-names>M</given-names></name></person-group><article-title>GATA-3 represses gp91phox gene expression in eosinophil-committed HL-60-C15 cells</article-title><source>FEBS Lett</source><year>1998</year><volume>436</volume><fpage>390</fpage><lpage>394</lpage><pub-id pub-id-type="pmid">9801155</pub-id><pub-id pub-id-type="doi">10.1016/S0014-5793(98)01182-X</pub-id></citation></ref><ref id="B87"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fraser</surname><given-names>JD</given-names></name><name><surname>Martinez</surname><given-names>V</given-names></name><name><surname>Straney</surname><given-names>R</given-names></name><name><surname>Briggs</surname><given-names>MR</given-names></name></person-group><article-title>DNA binding and transcription activation specificity of hepatocyte nuclear factor 4</article-title><source>Nucleic Acids Res</source><year>1998</year><volume>26</volume><fpage>2702</fpage><lpage>2707</lpage><pub-id pub-id-type="pmid">9592157</pub-id><pub-id pub-id-type="doi">10.1093/nar/26.11.2702</pub-id></citation></ref><ref id="B88"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zappavigna</surname><given-names>V</given-names></name><name><surname>Renucci</surname><given-names>A</given-names></name><name><surname>Izpisua-Belmonte</surname><given-names>JC</given-names></name><name><surname>Urier</surname><given-names>G</given-names></name><name><surname>Peschle</surname><given-names>C</given-names></name><name><surname>Duboule</surname><given-names>D</given-names></name></person-group><article-title>HOX4 genes encode transcription factors with potential auto- and cross-regulatory capacities</article-title><source>Embo J</source><year>1991</year><volume>10</volume><fpage>4177</fpage><lpage>4187</lpage><pub-id pub-id-type="pmid">1756725</pub-id></citation></ref><ref id="B89"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Scheidereit</surname><given-names>C</given-names></name><name><surname>Cromlish</surname><given-names>JA</given-names></name><name><surname>Gerster</surname><given-names>T</given-names></name><name><surname>Kawakami</surname><given-names>K</given-names></name><name><surname>Balmaceda</surname><given-names>CG</given-names></name><name><surname>Currie</surname><given-names>RA</given-names></name><name><surname>Roeder</surname><given-names>RG</given-names></name></person-group><article-title>A human lymphoid-specific transcription factor that activates immunoglobulin genes is a homoeobox protein</article-title><source>Nature</source><year>1988</year><volume>336</volume><fpage>551</fpage><lpage>557</lpage><pub-id pub-id-type="pmid">2904654</pub-id><pub-id pub-id-type="doi">10.1038/336551a0</pub-id></citation></ref><ref id="B90"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kastan</surname><given-names>MB</given-names></name><name><surname>Zhan</surname><given-names>Q</given-names></name><name><surname>el-Deiry</surname><given-names>WS</given-names></name><name><surname>Carrier</surname><given-names>F</given-names></name><name><surname>Jacks</surname><given-names>T</given-names></name><name><surname>Walsh</surname><given-names>WV</given-names></name><name><surname>Plunkett</surname><given-names>BS</given-names></name><name><surname>Vogelstein</surname><given-names>B</given-names></name><name><surname>Fornace</surname><given-names>AJ</given-names><suffix>Jr</suffix></name></person-group><article-title>A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia</article-title><source>Cell</source><year>1992</year><volume>71</volume><fpage>587</fpage><lpage>597</lpage><pub-id pub-id-type="pmid">1423616</pub-id><pub-id pub-id-type="doi">10.1016/0092-8674(92)90593-2</pub-id></citation></ref><ref id="B91"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>CP</given-names></name><name><surname>Shen</surname><given-names>WF</given-names></name><name><surname>Rozenfeld</surname><given-names>S</given-names></name><name><surname>Lawrence</surname><given-names>HJ</given-names></name><name><surname>Largman</surname><given-names>C</given-names></name><name><surname>Cleary</surname><given-names>ML</given-names></name></person-group><article-title>Pbx proteins display hexapeptide-dependent cooperative DNA binding with a subset of Hox proteins</article-title><source>Genes Dev</source><year>1995</year><volume>9</volume><fpage>663</fpage><lpage>674</lpage><pub-id pub-id-type="pmid">7729685</pub-id><pub-id pub-id-type="doi">10.1101/gad.9.6.663</pub-id></citation></ref><ref id="B92"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Petrucco</surname><given-names>S</given-names></name><name><surname>Wellauer</surname><given-names>PK</given-names></name><name><surname>Hagenbuchle</surname><given-names>O</given-names></name></person-group><article-title>The DNA-binding activity of transcription factor PTF1 parallels the synthesis of pancreas-specific mRNAs during mouse development</article-title><source>Mol Cell Biol</source><year>1990</year><volume>10</volume><fpage>254</fpage><lpage>264</lpage><pub-id pub-id-type="pmid">2294404</pub-id></citation></ref><ref id="B93"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tini</surname><given-names>M</given-names></name><name><surname>Fraser</surname><given-names>RA</given-names></name><name><surname>Giguere</surname><given-names>V</given-names></name></person-group><article-title>Functional interactions between retinoic acid receptor-related orphan nuclear receptor (ROR alpha) and the retinoic acid receptors in the regulation of the gamma F-crystallin promoter</article-title><source>J Biol Chem</source><year>1995</year><volume>270</volume><fpage>20156</fpage><lpage>20161</lpage><pub-id pub-id-type="pmid">7650034</pub-id><pub-id pub-id-type="doi">10.1074/jbc.270.34.20156</pub-id></citation></ref><ref id="B94"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>LJ</given-names></name><name><surname>Giam</surname><given-names>CZ</given-names></name></person-group><article-title>Interaction of the human T-cell lymphotrophic virus type I (HTLV-I) transcriptional activator Tax with cellular factors that bind specifically to the 21-base-pair repeats in the HTLV-I enhancer</article-title><source>Proc Natl Acad Sci USA</source><year>1991</year><volume>88</volume><fpage>11445</fpage><lpage>11449</lpage><pub-id pub-id-type="pmid">1763059</pub-id><pub-id pub-id-type="doi">10.1073/pnas.88.24.11445</pub-id></citation></ref><ref id="B95"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ladias</surname><given-names>JA</given-names></name><name><surname>Karathanasis</surname><given-names>SK</given-names></name></person-group><article-title>Regulation of the apolipoprotein AI gene by ARP-1, a novel member of the steroid receptor superfamily</article-title><source>Science</source><year>1991</year><volume>251</volume><fpage>561</fpage><lpage>565</lpage><pub-id pub-id-type="pmid">1899293</pub-id><pub-id pub-id-type="doi">10.1126/science.1899293</pub-id></citation></ref><ref id="B96"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nakamura</surname><given-names>T</given-names></name><name><surname>Okuyama</surname><given-names>S</given-names></name><name><surname>Okamoto</surname><given-names>S</given-names></name><name><surname>Nakajima</surname><given-names>T</given-names></name><name><surname>Sekiya</surname><given-names>S</given-names></name><name><surname>Oda</surname><given-names>K</given-names></name></person-group><article-title>Down-regulation of the cyclin A promoter in differentiating human embryonal carcinoma cells is mediated by depletion of ATF-1 and ATF-2 in the complex at the ATF/CRE site</article-title><source>Exp Cell Res</source><year>1995</year><volume>216</volume><fpage>422</fpage><lpage>430</lpage><pub-id pub-id-type="pmid">7843287</pub-id><pub-id pub-id-type="doi">10.1006/excr.1995.1053</pub-id></citation></ref><ref id="B97"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>White</surname><given-names>JH</given-names></name><name><surname>McIllhinney</surname><given-names>RA</given-names></name><name><surname>Wise</surname><given-names>A</given-names></name><name><surname>Ciruela</surname><given-names>F</given-names></name><name><surname>Chan</surname><given-names>WY</given-names></name><name><surname>Emson</surname><given-names>PC</given-names></name><name><surname>Billinton</surname><given-names>A</given-names></name><name><surname>Marshall</surname><given-names>FH</given-names></name></person-group><article-title>The GABAB receptor interacts directly with the related transcription factors CREB2 and ATFx</article-title><source>Proc Natl Acad Sci USA</source><year>2000</year><volume>97</volume><fpage>13967</fpage><lpage>13972</lpage><pub-id pub-id-type="pmid">11087824</pub-id><pub-id pub-id-type="doi">10.1073/pnas.240452197</pub-id></citation></ref><ref id="B98"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rooney</surname><given-names>JW</given-names></name><name><surname>Sun</surname><given-names>YL</given-names></name><name><surname>Glimcher</surname><given-names>LH</given-names></name><name><surname>Hoey</surname><given-names>T</given-names></name></person-group><article-title>Novel NFAT sites that mediate activation of the interleukin-2 promoter in response to T-cell receptor stimulation</article-title><source>Mol Cell Biol</source><year>1995</year><volume>15</volume><fpage>6299</fpage><lpage>6310</lpage><pub-id pub-id-type="pmid">7565783</pub-id></citation></ref><ref id="B99"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pierrou</surname><given-names>S</given-names></name><name><surname>Hellqvist</surname><given-names>M</given-names></name><name><surname>Samuelsson</surname><given-names>L</given-names></name><name><surname>Enerback</surname><given-names>S</given-names></name><name><surname>Carlsson</surname><given-names>P</given-names></name></person-group><article-title>Cloning and characterization of seven human forkhead proteins: binding site specificity and DNA bending</article-title><source>Embo J</source><year>1994</year><volume>13</volume><fpage>5002</fpage><lpage>5012</lpage><pub-id pub-id-type="pmid">7957066</pub-id></citation></ref><ref id="B100"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zweidler-Mckay</surname><given-names>PA</given-names></name><name><surname>Grimes</surname><given-names>HL</given-names></name><name><surname>Flubacher</surname><given-names>MM</given-names></name><name><surname>Tsichlis</surname><given-names>PN</given-names></name></person-group><article-title>Gfi-1 encodes a nuclear zinc finger protein that binds DNA and functions as a transcriptional repressor</article-title><source>Mol Cell Biol</source><year>1996</year><volume>16</volume><fpage>4024</fpage><lpage>4034</lpage><pub-id pub-id-type="pmid">8754800</pub-id></citation></ref><ref id="B101"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Overdier</surname><given-names>DG</given-names></name><name><surname>Porcella</surname><given-names>A</given-names></name><name><surname>Costa</surname><given-names>RH</given-names></name></person-group><article-title>The DNA-binding specificity of the hepatocyte nuclear factor 3/forkhead domain is influenced by amino-acid residues adjacent to the recognition helix</article-title><source>Mol Cell Biol</source><year>1994</year><volume>14</volume><fpage>2755</fpage><lpage>2766</lpage><pub-id pub-id-type="pmid">8139574</pub-id></citation></ref><ref id="B102"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Frain</surname><given-names>M</given-names></name><name><surname>Swart</surname><given-names>G</given-names></name><name><surname>Monaci</surname><given-names>P</given-names></name><name><surname>Nicosia</surname><given-names>A</given-names></name><name><surname>Stampfli</surname><given-names>S</given-names></name><name><surname>Frank</surname><given-names>R</given-names></name><name><surname>Cortese</surname><given-names>R</given-names></name></person-group><article-title>The liver-specific transcription factor LF-B1 contains a highly diverged homeobox DNA binding domain</article-title><source>Cell</source><year>1989</year><volume>59</volume><fpage>145</fpage><lpage>157</lpage><pub-id pub-id-type="pmid">2571419</pub-id><pub-id pub-id-type="doi">10.1016/0092-8674(89)90877-5</pub-id></citation></ref><ref id="B103"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Petronini</surname><given-names>PG</given-names></name><name><surname>Alfieri</surname><given-names>R</given-names></name><name><surname>Campanini</surname><given-names>C</given-names></name><name><surname>Borghetti</surname><given-names>AF</given-names></name></person-group><article-title>Effect of an alkaline shift on induction of the heat shock response in human fibroblasts</article-title><source>J Cell Physiol</source><year>1995</year><volume>162</volume><fpage>322</fpage><lpage>329</lpage><pub-id pub-id-type="pmid">7860640</pub-id><pub-id pub-id-type="doi">10.1002/jcp.1041620304</pub-id></citation></ref><ref id="B104"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nelms</surname><given-names>K</given-names></name><name><surname>Hromas</surname><given-names>R</given-names></name><name><surname>Van Ness</surname><given-names>B</given-names></name></person-group><article-title>Identification of a second inducible DNA-protein interaction in the kappa immunoglobulin enhancer</article-title><source>Nucleic Acids Res</source><year>1990</year><volume>18</volume><fpage>1037</fpage><lpage>1043</lpage><pub-id pub-id-type="pmid">2107525</pub-id><pub-id pub-id-type="doi">10.1093/nar/18.4.1037</pub-id></citation></ref><ref id="B105"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Teng</surname><given-names>CT</given-names></name></person-group><article-title>Estrogen response module of the mouse lactoferrin gene contains overlapping chicken ovalbumin upstream promoter transcription factor and estrogen receptor-binding elements</article-title><source>Mol Endocrinol</source><year>1992</year><volume>6</volume><fpage>355</fpage><lpage>364</lpage><pub-id pub-id-type="pmid">1584212</pub-id><pub-id pub-id-type="doi">10.1210/me.6.3.355</pub-id></citation></ref><ref id="B106"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Monaci</surname><given-names>P</given-names></name><name><surname>Nicosia</surname><given-names>A</given-names></name><name><surname>Cortese</surname><given-names>R</given-names></name></person-group><article-title>Two different liver-specific factors stimulate in vitro transcription from the human alpha 1-antitrypsin promoter</article-title><source>Embo J</source><year>1988</year><volume>7</volume><fpage>2075</fpage><lpage>2087</lpage><pub-id pub-id-type="pmid">3262058</pub-id></citation></ref><ref id="B107"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Willy</surname><given-names>PJ</given-names></name><name><surname>Umesono</surname><given-names>K</given-names></name><name><surname>Ong</surname><given-names>ES</given-names></name><name><surname>Evans</surname><given-names>RM</given-names></name><name><surname>Heyman</surname><given-names>RA</given-names></name><name><surname>Mangelsdorf</surname><given-names>DJ</given-names></name></person-group><article-title>LXR, a nuclear receptor that defines a distinct retinoid response pathway</article-title><source>Genes Dev</source><year>1995</year><volume>9</volume><fpage>1033</fpage><lpage>1045</lpage><pub-id pub-id-type="pmid">7744246</pub-id><pub-id pub-id-type="doi">10.1101/gad.9.9.1033</pub-id></citation></ref><ref id="B108"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Koizumi</surname><given-names>S</given-names></name><name><surname>Suzuki</surname><given-names>K</given-names></name><name><surname>Ogra</surname><given-names>Y</given-names></name><name><surname>Yamada</surname><given-names>H</given-names></name><name><surname>Otsuka</surname><given-names>F</given-names></name></person-group><article-title>Transcriptional activity and regulatory protein binding of metal-responsive elements of the human metallothionein-IIA gene</article-title><source>Eur J Biochem</source><year>1999</year><volume>259</volume><fpage>635</fpage><lpage>642</lpage><pub-id pub-id-type="pmid">10092847</pub-id><pub-id pub-id-type="doi">10.1046/j.1432-1327.1999.00069.x</pub-id></citation></ref><ref id="B109"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dean</surname><given-names>DC</given-names></name><name><surname>Blakeley</surname><given-names>MS</given-names></name><name><surname>Newby</surname><given-names>RF</given-names></name><name><surname>Ghazal</surname><given-names>P</given-names></name><name><surname>Hennighausen</surname><given-names>L</given-names></name><name><surname>Bourgeois</surname><given-names>S</given-names></name></person-group><article-title>Forskolin inducibility and tissue-specific expression of the fibronectin promoter</article-title><source>Mol Cell Biol</source><year>1989</year><volume>9</volume><fpage>1498</fpage><lpage>1506</lpage><pub-id pub-id-type="pmid">2542772</pub-id></citation></ref><ref id="B110"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dressler</surname><given-names>GR</given-names></name><name><surname>Douglass</surname><given-names>EC</given-names></name></person-group><article-title>Pax-2 is a DNA-binding protein expressed in embryonic kidney and Wilms tumor</article-title><source>Proc Natl Acad Sci USA</source><year>1992</year><volume>89</volume><fpage>1179</fpage><lpage>1183</lpage><pub-id pub-id-type="pmid">1311084</pub-id><pub-id pub-id-type="doi">10.1073/pnas.89.4.1179</pub-id></citation></ref><ref id="B111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kozmik</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Dorfler</surname><given-names>P</given-names></name><name><surname>Adams</surname><given-names>B</given-names></name><name><surname>Busslinger</surname><given-names>M</given-names></name></person-group><article-title>The promoter of the CD19 gene is a target for the B-cell-specific transcription factor BSAP</article-title><source>Mol Cell Biol</source><year>1992</year><volume>12</volume><fpage>2662</fpage><lpage>2672</lpage><pub-id pub-id-type="pmid">1375324</pub-id></citation></ref><ref id="B112"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mauhin</surname><given-names>V</given-names></name><name><surname>Lutz</surname><given-names>Y</given-names></name><name><surname>Dennefeld</surname><given-names>C</given-names></name><name><surname>Alberga</surname><given-names>A</given-names></name></person-group><article-title>Definition of the DNA-binding site repertoire for the Drosophila transcription factor SNAIL</article-title><source>Nucleic Acids Res</source><year>1993</year><volume>21</volume><fpage>3951</fpage><lpage>3957</lpage><pub-id pub-id-type="pmid">8371971</pub-id><pub-id pub-id-type="doi">10.1093/nar/21.17.3951</pub-id></citation></ref><ref id="B113"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sap</surname><given-names>J</given-names></name><name><surname>de Magistris</surname><given-names>L</given-names></name><name><surname>Stunnenberg</surname><given-names>H</given-names></name><name><surname>Vennstrom</surname><given-names>B</given-names></name></person-group><article-title>A major thyroid hormone response element in the third intron of the rat growth hormone gene</article-title><source>Embo J</source><year>1990</year><volume>9</volume><fpage>887</fpage><lpage>896</lpage><pub-id pub-id-type="pmid">2155782</pub-id></citation></ref><ref id="B114"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Curie</surname><given-names>C</given-names></name><name><surname>Liboz</surname><given-names>T</given-names></name><name><surname>Bardet</surname><given-names>C</given-names></name><name><surname>Gander</surname><given-names>E</given-names></name><name><surname>Medale</surname><given-names>C</given-names></name><name><surname>Axelos</surname><given-names>M</given-names></name><name><surname>Lescure</surname><given-names>B</given-names></name></person-group><article-title>Cis and trans-acting elements involved in the activation of Arabidopsis thaliana A1 gene encoding the translation elongation factor EF-1 alpha</article-title><source>Nucleic Acids Res</source><year>1991</year><volume>19</volume><fpage>1305</fpage><lpage>1310</lpage><pub-id pub-id-type="pmid">1840652</pub-id><pub-id pub-id-type="doi">10.1093/nar/19.6.1305</pub-id></citation></ref><ref id="B115"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lubon</surname><given-names>H</given-names></name><name><surname>Hennighausen</surname><given-names>L</given-names></name></person-group><article-title>Nuclear proteins from lactating mammary glands bind to the promoter of a milk protein gene</article-title><source>Nucleic Acids Res</source><year>1987</year><volume>15</volume><fpage>2103</fpage><lpage>2121</lpage><pub-id pub-id-type="pmid">3031588</pub-id><pub-id pub-id-type="doi">10.1093/nar/15.5.2103</pub-id></citation></ref></ref-list></back></article> 